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Chapter 3 
Enantioselective Total Synthesis of (+)-Nocardioazines A and B† 
 
3.1 INTRODUCTION 
Having accomplished the first total synthesis of (–)-lansai B (169), which 
illustrated the utility of our enantioselective formal (3 + 2) cycloaddition strategy in 
accessing related pyrroloindolines,1,2 we turned our attention to structurally related 
diketopiperazine-containing bis(pyrroloindoline) natural products (+)-nocardioazines A  
(171) and B (187). Both of these natural products were isolated in 2011 by Capon and 
coworkers as a new class of prenylated diketopiperazines from the Australian marine 
sediment-derived isolate, Nocardiopsis sp. (CMB-M0232).3 Nocardioazine A (171) has 
been found to be a potential multidrug resistance reversal candidate due to its P-
glycoprotein binding property.3 
Although these natural products appear quite similar structurally, close analysis 
reveals subtle differences in the relative stereochemistry of the pyrroloindoline units. 
                                                
† Part of this chapter was published as the following communications: Wang, H.; 
Reisman, S. E. Angew. Chem. Int. Ed. 2014, 53, 6206. 
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Whereas lansai B (169) is composed of two exo-pyrroloindolines, 171 and 187 each 
possess one endo- and one exo-pyrroloindoline. Moreover, the endo- and exo-
pyrroloindolines are in the opposite enantiomeric series, which is necessary to 
geometrically accommodate the macrocycle of 171.  
Figure 3.1. Structures of (+)-nocardioazines A and B 
 
 
3.1.1 Proposed Biosynthesis of Nocardioazines A and B 
Biosynthetically, it is proposed that both nocardioazines A and B are synthesized 
in bacteria from L-tryptophan cyclic dimer 252 (Scheme 3.1), which is alkylated at both 
C3 positions with either a methyl or a prenyl group to provide imine intermediate 253.3 
The diketopiperazine (DKP) nitrogen atoms would then cyclize to form the 
pyrroloindoline core, providing nocardioazine B (ent-187). ent-187 is proposed to 
undergo two subsequent oxidation reactions to produce hydroxyl-epoxide 254. The 
elimination of water facilitated by the indoline nitrogen then forms nocardioazine A (ent-
171). 
It is important to note that the naturally abundant L-tryptophan series dictates the 
absolute stereochemistry at the DKP core to be of the (S)-configuration, as proposed in 
the isolation paper.3 Our total synthesis work, as will be described in this chapter, and 
related studies by Ye and coworkers4 have corrected the absolute stereochemistry to be of 
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the (R)-configurations, indicating that the nocardioazine family are derived from the rare 
D-tryptophan series. In alignment with this claim, Capon and coworkers co-isolated 
cyclo-(L-Trp-L-Trp) and cyclo-(L-Trp-D-Trp) along with the nocardioazines.3 It is 
suggested that cyclo-(L-Trp-D-Trp) could be the biosynthetic precursor of nocardioazines 
A and B; however, such a hypothesis requires that the L-Trp fragment undergoes 
epimerization at some point during the biological pathway. 
Scheme 3.1. Proposed biosynthetic origins of nocardioazines A and B 
 
 
3.1.2 The Total Synthesis of (–)-Nocardioazine B by Ye 
At the outset of our endeavor toward nocardioazines A (171) and B (187) in 2011, 
there were no reported total syntheses of these diketopiperazine-containing 
pyrroloindoline natural products. Only a year afterwards, Ye and coworkers 
accomplished the first total synthesis of (–)-nocardioazine B (ent-187).4  
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Scheme 3.2. Preparation of nocardioazine B fragments from tryptophans by Ye 
 
Starting from D-tryptophan (255), a well-established three-step procedure 
provided exo-Br-pyrroloindoline 184 in good yield (Scheme 3.2). Utilizing methodology 
developed by Rainier and coworkers,5 the bromide of pyrroloindoline exo-184 was 
converted to a methyl group via a highly strained cyclopropane intermediate (See Chapter 
2, Scheme 2.3 for detailed discussion), which provided the endo-pyrroloindoline 
fragment endo-186. In order to assemble the eastern fragment of the natural product, L-
tryptophan was converted to ent-184 following the same procedure, and was subjected to 
a Keck radical alkylation, as utilized by the Danishefsky group.6 The allyl group in 256 
was subjected to a Johnson-Lemieux oxidation to form the corresponding aldehyde, 
which underwent a Wittig olefination reaction to provide the prenyl group of the 
pyrroloindoline fragment exo-257. 
After preparation of both fragments, a step-wise peptide coupling strategy was 
pursued to form the DKP core (Scheme 3.3): endo-186 was hydrolyzed to give acid 258, 
and the Boc groups in exo-257 were then removed to provide amine 259. Carboxylic acid 
258 and amine 259 were treated with peptide coupling reagent HATU to form dipeptide 
260, which was subsequently methylated at the aniline nitrogen under reductive 
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amination conditions. Upon removal of the two Boc protecting groups, the resulting 
secondary amine intermediate cyclized in situ to provide the central DKP and completed 
the total synthesis of (–)-nocardioazine B (ent-187). Through de novo exercise, Ye and 
coworkers were able to correct the originally proposed absolute stereochemistry of the 
natural product by comparison of the optical rotation signs, confirming that (+)-
nocardioazine B (187, Figure 3.1) is the naturally occurring form. The question left 
unanswered was the absolute configuration of nocardioazine A (171), although it was 
presumed that it carried the same absolute configuration as 187. 
Scheme 3.3. Endgame of (–)-nocardioazine B synthesis by Ye 
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the construction of subsequent stereocenters. However, we believed that a more efficient 
synthesis of 171 and 187 could be born by harnessing the power of asymmetric catalysis 
and starting from achiral starting materials.  
We took particular note of the fact that the endo- and exo-pyrroloindolines are of 
the opposite enantiomeric series, a structural element that is necessary to geometrically 
accommodate the macrocycle of 171. This interesting stereochemical relationship makes 
171 and 187 appealing synthetic targets for asymmetric catalysis, where selection of the 
appropriate enantiomer of catalyst dictates the absolute stereochemistry of the 
pyrroloindoline building blocks.  
Scheme 3.4. Retrosynthetic analysis of (+)-nocardioazines A and B 
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(187). On the other hand, cross metathesis with methacrolein and subsequent reduction 
would generate allylic alcohol 261, which provides a suitable handle for cyclization and 
sets the stage for a final epoxidation event to complete the total synthesis of 
nocardioazine A (171). The divergent intermediate 262 is proposed to be accessed by 
coupling pyrroloindolines endo-264 and exo-265. In previous studies we have 
demonstrated that the exo-diastereomer can be epimerized to the corresponding endo-
diastereomer, thus the preparation of both endo-264 and exo-265 would provide a path 
forward.1 
 
3.2 TOTAL SYNTHESIS OF (+)-NOCARDIOAZINE B 
In the forward sense, treatment of a solution of N-methyl-3-allyl indole (266) and 
acrylate 61a with (S)-BINOL (20 mol %) and SnCl4 (1.2 equiv) delivered exo-
pyrroloindoline 265 in 52% yield and 90% ee (Scheme 3.5). These conditions were 
highly diastereoselective for exo-265 (19:1); however, the yield is modest due to allyl 
migration from C3 to C2 of the indole under the reaction conditions.7 Neither addition of 
2,6-dibromophenol nor use of other catalysts improved the yield of 265. Cleavage of the 
TFA group using TfOH in anhydrous methanol provided, upon basic workup, exo-amine 
267. 
Scheme 3.5. Preparation of exo-pyrroloindoline 267 fragment 
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On the other hand, treatment of N-allylindole 268 and benzyl 
trifluoroacetamidoacrylate (61b) with (R)-3,3’-dichloro-BINOL (20 mol %), SnCl4 (1.6 
equiv), and 2,6-dibromophenol (0.4 equiv) furnished exo-pyrroloindoline 269 in 57% 
yield and 98% ee (Scheme 3.6). It is noteworthy that additive 2,6-dibromophenol 
significantly improves the ee of this reaction, compared to the observed 92% ee without 
it.2 The modest yield of exo-269 results from the moderate diastereoselectivity (5.8:1) of 
the transformation. In this case, benzyl acrylate 61b was employed instead of methyl 
acrylate 61a because the dr was improved and the exo- and endo- diastereomers were 
more readily separated. In order to prepare the corresponding carboxylic acid 271, benzyl 
ester was first converted to methyl ester 270 using K2CO3 in methanol. Treatment of exo-
270 with LiHMDS at low temperatures followed by acetic acid quench provided the 
thermodynamically favored endo diastereomer 264, which was deprived of the methyl 
ester with BBr3 to deliver endo-pyrroloindoline acid 271.  
Scheme 3.6. Preparation of endo-pyrroloindoline 271 fragment 
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pyrroloindolines in the lansai B (169) synthesis (Chapter 2), mixing of endo-acid 271 and 
exo-amine 267 in the presence of BOP-Cl furnished the desired dipeptide 272, albeit in 
low yield due to side reactions including epimerization and decomposition of 271 (entry 
1, Table 3.1). After considerable optimization, we discovered that the nature of the base 
in the peptide coupling plays a key role in determining the reactivity. When DMAP or 
pyridine was used, the major product was the anhydride derived from dimerization of 
acid 271. Fortunately, 2,4,6-collidine was found to be effective in favoring product 
formation over anhydride production to provide 45% yield of product (entry 4). The yield 
was further improved to 81% by slow addition of acid 271 to 2.0 equiv amine 267 (entry 
6). Importantly, the unreacted amine 267 could be recovered by silica gel 
chromatography. When compared to the challenges encountered in the coupling of exo-
pyrroloindolines, the ability to couple exo-267 and endo-271 reveals that, in addition to 
the identity of the N-substituents, the relative stereochemistry of the pyrroloindoline 
coupling partners is a key determinate in the ease of peptide formation.  
Table 3.1. Peptide coupling between exo-267 and endo-271 
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Saponification of 272 with LiOH generated amino acid 273, which could be 
detected by LC-MS (Scheme 3.7). Interestingly, acidification of the reaction mixture with 
1M HCl delivered DKP 263, which represents an unusually facile DKP cyclization. 
Subsequent palladium-catalyzed deallylation of 263 in the presence of 1,3-
dimethylbarbituric acid as the allyl scavenger gave free amine 262.8 Cross metathesis of 
262 with 2-methyl-2-butene (274) provided (+)-nocardioazine B (187).9 Thus, the 
enantioselective total synthesis of (+)-187 was completed in nine linear steps and 21% 
overall yield from 3-methylindole. 
Scheme 3.7. Endgame of (+)-nocardioazine B synthesis 
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(Scheme 3.8).10 Luche reduction followed by Finkelstein chlorination provided allyl 
chloride 276. Gratifyingly, treatment of 276 with tetrabutylammonium iodide (TBAI) and 
base in acetonitrile at 80 °C promoted intramolecular N-alkylation, furnishing macrocycle 
277. Interestingly, the base was found to be important in this SN2 process: use of a less 
bulky base like triethylamine provided lower yields due to competing displacement of 
chloride to form an ammonium salt. Interestingly, the 1H NMR spectra of alkene 277 
revealed two interconverting conformations, adding difficulties to the elucidation of its 
structure. Eventually, the structure of this unusual macrocycle 277 was confirmed by X-
ray crystallography, setting the stage for the final epoxidation step. 
Scheme 3.8. Preparation of macrocyclic alkene 277 
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catalysts, failed to produce the natural product; instead, the major product was unstable 
N-oxide 278 (Scheme 3.9), which was characterized by a significant downfield shift of 
the N-methyl group in the 1H NMR. Use of excess oxidant or efforts to isolate 278 and 
resubject it to epoxidation conditions were also unsuccessful, revealing that the 
trisubstituted alkenes of 277 and 278 are remarkably inert toward epoxidation. The origin 
of this effect is unclear; however, inspection of the crystal structure of alkene 277 
suggests that it is not simply steric shielding of the double bond.   
Scheme 3.9. Attempts to install the epoxide 
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not occur, presumably due to the lower acidity of the aniline N-H in 281. Alternatively, 
the primary alcohol could be converted to the mesylate (282). Unfortunately, either 
epimerization or no reaction was observed when treating 282 with a wide array of base. 
Other leaving groups including iodide and triflate were also explored, but no cyclization 
product was detected in either case. The lower reactivity toward cyclization of epoxide 
282 versus alkene 277 is not entirely surprising due to the loss of reactivity gained from 
the allylic halide in 277. 
Scheme 3.10. Attempts to promote the last-stage cyclization 
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Scheme 3.11. Early incorporation of epoxide 
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Scheme 3.12. Intermolecular alkylation attempts 
 
Scheme 3.13. Endgame of (+)-nocardioazine A synthesis 
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resulted in saponification of the methyl esters and hydrolysis of the TFA groups to give 
bis(amino acid) 293. We were pleased to find that subjection of 293 to 
bromotripyrrolidinophosphonium hexafluorophosphate (PyBroP, a peptide coupling 
reagent) in DMF promoted intramolecular DKP formation to afford (+)-nocardioazine A 
(171). The synthesis of (+)-171 requires only nine steps and proceeds in 11% overall 
yield from 3-allylindole. Moreover, these findings establish the viability of 
macrocyclization by intramolecular DKP formation.  
Through this process, we also established that the naturally isolated nocardioazine 
A (171) possesses the same absolute stereo configurations as nocardioazine B (187), 
suggesting that both natural products might be produced from the same biological source, 
namely cyclo-(L-Trp-D-Trp). 
 
3.4 CONCLUDING REMARKS 
In summary, the enantioselective total syntheses of the diketopiperazin-containing 
pyrroloindoline natural products (+)-nocardioazine A (171) and B (187) were 
accomplished. These studies demonstrate the utility of enantioselective formal (3 + 2) 
cycloaddition reactions to prepare highly functionalized pyrroloindolines for applications 
in total synthesis. In addition, subtle changes in the relative stereochemistry and nitrogen 
substitution patterns of pyrroloindolines were shown to significantly influence the ability 
to prepare bis(pyrroloindolines) by DKP formation. Further investigations of 171 as an 
inhibitor of P-glycoprotein are ongoing with collaboration with the Chang laboratory in 
UC San Diego. 
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3.5 EXPERIMENTAL SECTION 
3.5.1 Materials and Methods 
Unless otherwise stated, reactions were performed under a nitrogen atmosphere 
using freshly dried solvents. Tetrahydrofuran (THF), methylene chloride (CH2Cl2), 
acetonitrile (MeCN), dimethylformamide (DMF), and toluene (PhMe) were dried by 
passing through activated alumina columns. Unless otherwise stated, chemicals and 
reagents were used as received. N,N-Diisopropylethamine (DIPEA) was distilled over 
calcium hydride prior to use. All reactions were monitored by thin-layer chromatography 
using EMD/Merck silica gel 60 F254 pre-coated plates (0.25 mm) and were visualized by 
UV, p-anisaldehyde, or KMnO4 staining. Flash column chromatography was performed 
either as described by Still et al.13 using silica gel (particle size 0.032-0.063) purchased 
from Silicycle or using pre-packaged RediSep®Rf columns on a CombiFlash Rf system 
(Teledyne ISCO Inc.). Optical rotations were measured on a Jasco P-2000 polarimeter 
using a 100 mm path-length cell at 589 nm. 1H and 13C NMR spectra were recorded on a 
Varian 400 MR (at 400 MHz and 101 MHz, respectively), a Bruker 400 equipped with a 
cryoprobe (at 400 MHz and 101 MHz, respectively), a Varian Inova 500 (at 500 MHz 
and 126 MHz, respectively), or a Varian Inova 600 (at 600 MHz and 150 MHz, 
respectively), and are reported relative to internal CHCl3 (1H, δ = 7.26), CHDCl2 (1H, δ = 
5.32), CD2HOD (1H, δ = 3.31), MeCN-d2 (1H, δ = 1.94), or DMSO-d5 (1H, δ = 2.50), 
and CDCl3 (13C, δ = 77.0), CD2Cl2 (13C, δ = 54.0), CD3OD (13C, δ = 49.0), MeCN-d3 
(13C, δ = 118.3), or DMSO-d6 (13C, δ = 40.0). Data for 1H NMR spectra are reported as 
follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), integration). 
Multiplicity and qualifier abbreviations are as follows: s = singlet, d = doublet, t = triplet, 
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q = quartet, m = multiplet, br = broad, app = apparent. IR spectra were recorded on a 
Perkin Elmer Paragon 1000 spectrometer and are reported in frequency of absorption 
(cm–1). HRMS were acquired using an Agilent 6200 Series TOF with an Agilent G1978A 
Multimode source in electrospray ionization (ESI), atmospheric pressure chemical 
ionization (APCI), or mixed (MM) ionization mode. Analytical chiral HPLC was 
performed with an Agilent 1100 Series HPLC utilizing Chiralpak AD or Chiralcel OD-H 
columns (4.6 mm x 25 cm) obtained from Daicel Chemical Industries, Ltd with 
visualization at 254 nm. Preparative HPLC was performed with an Agilent 1100 Series 
HPLC utilizing an Agilent Eclipse XDB-C18 5μm column (9.4 x 250 mm) or an Agilent 
Zorbax RX-SIL 5µm column (9.4 x 250 mm). Melting points were determined using a 
Büchi B-545 capillary melting point apparatus and the values reported are uncorrected. 
3.5.2 Preparative Procedures and Spectroscopic Data 
Preparation of N-methyl-3-allylindole 266  
 
To a 500 mL flame-dried flask was added NaH (60%, 4.94 g, 123.6 mmol, 1.5 
equiv) and DMF (120 mL). Commercially aviallable 3-allylindole A-2 (12.95 g, 82.4 
mmol, 1.0 equiv) was transferred to the reaction flask via DMF (40 mL). After 90 
minutes, methyl iodide (7.7 mL, 123.6 mmol, 1.5 equiv) was added slowly, while the 
reaction flask was cooled using an ice-bath. After 1 hour, the reaction was diluted with 
EtOAc (100 mL) and carefully quenched with distilled water (300 mL). The mixture was 
separated and the aqueous layer was then extracted with EtOAc (2 x 200 mL). Combined 
DMF, 23 °C
(98% yield)
NaH
N
H
N
Me
A-2 266
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organic layers were washed with brine (3 x 300 mL) to get rid of DMF. It was dried over 
Na2SO4, filtered and concentrated down to a yellow oil. Flash chromatography (0% to 
10% EtOAc in hexanes) afforded N-methyl-3-allylindole 266, as a yellow oil (13.77 g, 
80.4 mmol, 98% yield). Spectral data matches that reported in the literature.14 
Preparation of N-methyl-3-allyl pyrroloindoline 265 
 
To a flame-dried flask was added N-methyl-3-allylindole 266 (1.0 g, 5.80 mmol, 
1.0 equiv), methyl acrylate 61a (1.15 g, 5.80 mmol, 1.0 equiv), (S)-BINOL (334 mg, 1.20 
mmol, 0.2 equiv), and DCM (30 mL). The reaction flask was covered with aluminum 
foil. SnCl4 (1M solution in DCM, 9.34 mL, 9.34 mmol, 1.6 equiv) was added at last. The 
reaction mixture was allowed to stir at room temperature for 24 hours. The solution was 
diluted with acetonitrile (12 mL) and quenched with 1M HCl (12 mL), followed by 
addition of distilled water (60 mL). The mixture was separated and the aqueous layer was 
extracted with EtOAc (3 x 60 mL). Combined organic layers were washed with saturated 
NaHCO3 solution (75 mL) and then brine (75 mL). It was dried over Na2SO4, filtered and 
concentrated down to give an orange oil. Flash chromatography (0% to 20% EtOAc in 
hexanes) afforded 3-allyl-pyrroloindoline 265 (19 : 1 mixture of exo:endo diastereomers 
by 1H NMR), as a thick orange oil (1.10 g, 2.99 mmol, 52% yield); A-3 was isolated as 
the major side product, resulting from C3 to C2 rearrangement. The mixture of 
diastereomers was further purified by flash chromatography (0% to 10% EtOAc in 
hexanes) to give major diastereomer 265 for characterization purposes. The enantiomeric 
N N
Me H
O
OMe
DCM, 23 °CN
Me 19 : 1 dr
90% ee
(52% yield)
9a (1.2 equiv)
(S)-BINOL
(20 mol %)
SnCl4 (1.2 equiv)
TFA
N
Me
HN
MeO
O
+ TFA
266 exo-265 A-3
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excess of exo-265 was determined to be 90% by chiral SFC analysis (AD, 2.5 mL/min, 
3% IPA in CO2, λ = 254 nm): tR(major) = 3.2 min, tR(minor) = 6.5 min. [α]D25 = +112° (c 
= 0.96, CHCl3); 1H NMR (500 MHz, CDCl3; compound exists as a 2.0:1 mixture of 
rotamers the major rotamer is denoted by *, minor rotamer denoted by §) δ 7.17 (t, J = 7.7 
Hz, 1H*, 1H§), 7.05 (d, J = 7.3 Hz, 1H*, 1H§), 6.84 (t, J = 8.1 Hz, 1H§), 6.77 (t, J = 7.5 
Hz, 1H*), 6.58 (d, J = 7.2 Hz, 1H§), 6.52 (d, J = 7.9 Hz, 1H*), 5.62 (s, 1H*), 5.60 – 5.45 
(m, 1H*, 1H§), 5.44 (s, 1H§), 5.15 – 5.04 (m, 2H*, 2H§), 4.64 (d, J = 5.5 Hz, 1H*), 4.38 – 
4.31 (m, 1H§), 3.81 (s, 3H*), 3.76 (s, 3H§), 3.10 (s, 3H*), 2.89 (s, 3H§), 2.64 (dd, J = 13.6, 
9.3 Hz, 1H*), 2.62 – 2.57 (m, 1H§), 2.54 (dd, J = 14.0, 6.7 Hz, 1H*, 1H§), 2.52 – 2.47 (m, 
1H§), 2.46 – 2.40 (m, 1H*), 2.32 (dd, J = 13.9, 8.4 Hz, 1H*), 2.19 – 2.11 (m, 1H§); 13C 
NMR (126 MHz, CDCl3) δ 172.5*, 170.5§, 158.8* (q, J = 37.1 Hz), 157.5§ (q, J = 38.0 
Hz), 150.2*§, 133.2*, 132.2§, 129.0§, 128.8*, 122.1*, 120.0§, 119.1*, 118.7§, 116.0* (q, J 
= 288.4 Hz), 115.8§ (app d, J = 285.2 Hz), 109.9§, 108.2*, 90.4*, 89.0§, 60.6§, 59.5*, 
57.3§, 53.4*, 52.9*, 52.4§, 42.1*, 41.6*, 41.0§, 39.0§, 36.8*, 35.4§ (both 1H and 13C spectra 
were taken using the enantiomer of 23); FTIR (NaCl, thin film): 3076, 3053, 3008, 2955, 
2918, 2848, 2829, 1751, 1693, 1641, 1608, 1490, 1435, 1357, 1302, 1203, 1158, 1061, 
1023, 994, 952, 925, 875, 854, 810, 795, 746 cm-1; HRMS (MM) calc’d for C18H20F3N2O3 
[M+H]+ 369.1421, found 369.1432. 
Preparation of exo-pyrroloindoline amine 267 
 
TfOH
exo-267
N N
Me H
O
OMe
(75% yield)
TFA
MeOH
exo-265
N N
Me H
O
OMe
H
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To a 200 mL flame-dried flask was added exo-3-allyl-pyrroloindoline 265 (6.57 g, 
17.8 mmol, 1.0 equiv) and dissolved with MeOH (90 mL). Triflic acid (15.7 mL, 178.4 
mmol, 10.0 equiv) was added slowly into reaction flask. The dark purple mixture was 
allowed to stir at room temperature for 50 hours. The solution was cautiously quenched 
with saturated NaHCO3 solution (150 mL). The mixture was separated and the aqueous 
layer was extracted with DCM (3 x 150 mL). Combined organic layers were dried over 
Na2SO4, filtered and concentrated down to give an orange oil. Flash chromatography (0% 
to 60% EtOAc in hexanes) afforded 3-allyl-pyrroloindoline amine exo-267 as a thick 
orange oil (3.60 g, 13.2 mmol, 75% yield). [α]D25 = +43° (c = 0.95, CHCl3); 1H NMR 
(500 MHz, CDCl3) δ 7.05 (td, J = 7.6, 1.3 Hz, 1H), 6.98 (dd, J = 7.4, 1.2 Hz, 1H), 6.61 
(td, J = 7.4, 1.0 Hz, 1H), 6.31 (d, J = 7.8 Hz, 1H), 5.67 (dddd, J = 16.7, 10.1, 7.9, 6.4 Hz, 
1H), 5.08 – 4.99 (m, 2H), 4.68 (s, 1H), 3.64 (s, 3H), 3.62 (dd, J = 10.4, 6.1 Hz, 1H), 2.78 
(s, 3H), 2.67 (s, 1H), 2.51 (ddt, J = 13.9, 6.5, 1.4 Hz, 1H), 2.41 (ddt, J = 13.7, 8.0, 1.1 Hz, 
1H), 2.34 (dd, J = 12.1, 6.1 Hz, 1H), 1.95 (dd, J = 12.2, 10.4 Hz, 1H); 13C NMR (126 
MHz, CDCl3) δ 173.8, 150.8, 134.0, 132.2, 127.9, 122.6, 117.6, 116.4, 104.9, 88.0, 58.9, 
56.0, 51.5, 44.1, 42.5, 30.9; FTIR (NaCl, thin film): 3344, 3073, 3050, 3024, 3003, 2950, 
2916, 1738, 1639, 1606, 1493, 1449, 1437, 1383, 1354, 1328, 1300, 1267, 1236, 1206, 
1166, 1140, 1121, 1105, 1073, 1019, 998, 973, 948, 918, 889, 817, 790, 741 cm-1; HRMS 
(MM) calc’d for C16H21N2O2 [M+H]+ 273.1598, found 273.1067. 
 
 
 
 
116
Chapter 3 – Enantioselective Total Synthesis of (+)-Nocardioazines A and B  
Preparation of N-allyl pyrroloindoline 269 
 
To a flame-dried flask was added N-allylindole 26815 (815 mg, 4.76 mmol, 1.0 
equiv), benzyl acrylate 61b16 (1.56 g, 5.71 mmol, 1.2 equiv), (R)-3,3’-Cl2-BINOL (338 
mg, 0.95 mmol, 0.2 equiv), 2,6-dibromo-phenol (480 mg, 1.90 mmol, 0.4 equiv) and 
DCM (35 mL). SnCl4 (1M solution in DCM, 7.62 mL, 7.62 mmol, 1.2 equiv) was added 
at last. The orange mixture was allowed to stir at room temperature for 42 hours. The 
solution was diluted with acetonitrile (12 mL) and quenched with 1M HCl (12 mL), 
followed by addition of distilled water (60 mL). The mixture was separated and the 
aqueous layer was extracted with ether (3 x 60 mL). Combined organic layers were 
washed with 3M NaOH solution (3 x 75 mL). It was dried over MgSO4, filtered and 
concentrated down to give yellow mixture of oil and solid. Flash chromatography (1% to 
8% EtOAc in hexanes) afforded major diastereomer exo-pyrroloindoline 269 as a thick 
orange oil (1.19 g, 2.68 mmol, 57% yield); minor diastereomer endo-pyrroloindoline A-4 
was also isolated as a thick orange oil (204 mg, 0.46 mmol, 10% yield). The enantiomeric 
excess of 269 was determined to be 98% by chiral SFC analysis (OJ, 2.5 mL/min, 6% 
IPA in CO2, λ = 254 nm): tR(major) = 5.7 min, tR(minor) = 4.4 min. The enantiomeric 
excess of A-4 was determined to be 93% by chiral SFC analysis (OJ, 2.5 mL/min, 2% 
IPA in CO2, λ = 254 nm): tR(major) = 5.7 min, tR(minor) = 4.4 min. Spectral data of both 
diastereomers matches that reported in the literature.2 
N N
Me
H TFA
O
OBn
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+
N
Me
N N
Me
H TFA
O
OBn
2,6-Br2-phenol (0.4 equiv)
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Preparation of N-allyl pyrroloindoline methyl ester 270 
 
N-Allyl pyrroloindoline benzyl ester 269 (1.11 g, 2.51 mmol, 1.0 equiv) was 
dissolved in dry methanol (25 mL); then K2CO3 (70 mg, 0.50 mmol, 0.2 equiv) was 
added as one portion. After running at room temperature for 6 hours, the reaction was 
quenched with 1M HCl (50 mL), and extracted with EtOAc (3 x 40 mL). Combined 
organic layer was washed with sodium bicarbonate saturated solution (50 mL) and then 
dried over Na2SO4, filtered and concentrated down to give yellow oil. Flash 
chromatography (0% to 15% EtOAc in hexanes) afforded corresponding methyl ester 
270, as a white solid (818 mg, 2.22 mmol, 89% yield). Spectral data matches that 
reported in the literature.3 
Preparation of endo-N-allyl pyrroloindoline 264 
 
N-Allyl pyrroloindoline methyl ester 270 (700 mg, 1.90 mmol) was dissolved in 
dry THF (16 mL) and brought to –78 °C. LiHMDS solution (1M in THF, 2.85 mL, 2.85 
mmol, 1.5 equiv) was added slowly to substrate in THF. After 1 hour, the reaction was 
quenched with acetic acid (1 mL) and warmed to room temperature. Then the reaction 
was quenched carefully with sodium bicarbonate saturated solution (40 mL). The 
aqueous layer was then extracted with EtOAc (3 x 50 mL). Combined organic layer was 
washed with brine (50 mL). It was then dried over Na2SO4, filtered, and concentrated 
N N
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O
OBn
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down to give a yellow oil. Flash chromatography (0% to 10% EtOAc in hexanes) 
afforded corresponding epimerized endo pyrroloindoline methyl ester 264, as a yellow oil 
(700 mg, 1.90 mmol, quantitative yield). [α]D25 = –200° (c = 1.62, CHCl3); spectral data 
matches that the corresponding enantiomer reported in the literature.3  
Preparation of endo-N-allyl pyrroloindoline carboxylic acid 271 
 
endo-N-Allyl pyrroloindoline methyl ester 264 (1.50 g, 4.07 mmol, 1.0 equiv) was 
added to a flame-dried 100 mL flask and dissolved in DCM (36 mL). The flask was then 
cooled to –78 °C and freshly prepared BBr3 in DCM solution (BBr3: 1.15 mL, 12.22 
mmol, 3.0 equiv; DCM: 12 mL) was added slowly into reaction flask. After 5 minutes, 
the reaction was allowed to warm to room temperature and stirred for 90 minutes. It was 
then quenched carefully with addition of distilled water (10 mL), then followed by 
addition of pH = 2.5 acidic buffer (40 mL, prepared by acidifying a 10% NaH2PO4 
aqueous solution by KHSO4 until pH reaches 2.5). The aqueous layer was extracted with 
EtOAc (4 x 40 mL). Combined organic layer was washed with brine (80 mL). It was then 
dried over Na2SO4, filtered, and concentrated down to give a yellow oil. Flash 
chromatography (0% to 20% EtOAc in hexanes, with 1% acetic acid) afforded 
corresponding pyrroloindoline carboxylic acid endo-271, as a brown foam (1.26 g, 3.56 
mmol, 88% yield). [α]D25 = –179° (c = 1.39, CHCl3); 1H NMR (500 MHz, CDCl3; 
compound exists as a 8.0 : 1 mixture of rotamers the major rotamer is denoted by *, 
minor rotamer denoted by §) δ 10.90 (s, 1H*, 1H§), 7.11 (td, J = 7.7, 1.3 Hz, 1H§), 7.07 
N N
Me
H TFA
O
OMe
endo-264
N N
Me
H TFA
O
OHBBr3, DCM,–78 to 23 °C
then H2O
(88% yield)
endo-271
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(dd, J = 7.4, 1.2 Hz, 1H§), 6.99 (td, J = 7.7, 1.3 Hz, 1H*), 6.95 (dd, J = 7.5, 1.2 Hz, 1H*), 
6.75 (td, J = 7.4, 1.0 Hz, 1H§), 6.57 (td, J = 7.4, 0.9 Hz, 1H*), 6.50 (d, J = 7.9 Hz, 1H§), 
6.39 (d, J = 7.9 Hz, 1H*), 5.85 (ddt, J = 17.3, 10.6, 5.4 Hz, 1H*), 5.81 – 5.72 (m, 1H§), 
5.59 (s, 1H*), 5.55 (d, J = 1.9 Hz, 1H§), 5.29 (dq, J = 17.2, 1.7 Hz, 1H*), 5.22 – 5.20 (m, 
1H§), 5.20 – 5.17 (m, 1H§), 5.15 (dq, J = 10.2, 1.5 Hz, 1H*), 5.06 (dd, J = 9.9, 5.4 Hz, 
1H§), 4.73 (dt, J = 8.7, 1.5 Hz, 1H*), 4.13 (qdt, J = 16.7, 5.1, 1.7 Hz, 2H*), 3.91 – 3.69 
(m, 2H§), 2.76 (dd, J = 13.2, 1.4 Hz, 1H*), 2.42 (dd, J = 13.1, 8.8 Hz, 1H*), 2.39 – 2.34 
(m, 1H§), 2.29 (dd, J = 13.4, 9.9 Hz, 1H§), 1.45 (s, 3H§), 1.43 (s, 3H*); 13C NMR (126 
MHz, CDCl3) δ 175.3§, 175.2*, 156.8 (q, JC-F = 37.0 Hz), 156.6 (q, J C-F= 37.5 Hz), 
149.1*, 147.3§, 133.8*, 133.1§, 132.4§, 131.8*, 128.9*, 128.5§, 122.2*, 121.4§, 118.7§, 
118.0*, 117.1§, 116.3*, 116.0* (q, JC-F = 288.5 Hz), 108.1§, 107.1*, 88.9§, 88.3*, 59.8§, 
59.6* (q, JC-F = 3.1 Hz), 52.2§, 50.4*, 48.8*, 46.2§, 42.3*, 41.1§, 25.2*, 22.0§; FTIR 
(NaCl, thin film): 3079, 3057, 3026, 2963, 2928, 2870, 2647, 2560, 1729, 1696, 1608, 
1491, 1448, 1352, 1314, 1253, 1210, 1184, 1145, 1106, 1093, 1083, 1027, 992, 942, 921, 
888, 854, 742 cm-1; HRMS (APCI) calc’d for C17H18F3N2O3 [M+H]+ 355.1264, found 
355.1275. 
Preparation of dipeptide 272 
 
To a 250 mL flame-dried flask was added 3-allyl-amine exo-267 (1.94 g, 7.11 
mmol, 2.0 equiv), BOP-Cl (1.81 g, 7.11 mmol, 2.0 equiv) and dissolved with DCM (93 
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BOP-Cl, collidine,
slow addition of 271
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mL), followed by addition of 2,4,6-collidine (1.08 mL, 8.18 mmol, 2.3 equiv). 
Carboxylic acid endo-271 (1.26 g, 3.56 mmol, 1.0 equiv) was dissolved in DCM (47 mL) 
and the resulting solution was added slowly into the reaction flask using a syringe pump 
over 12 hours. The resulting reaction solution was allowed to stir at room temperature for 
another 10 hours. The reaction was quenched with saturated NaHCO3 solution (200 mL). 
The mixture was separated and the aqueous layer was extracted with EtOAc (3 x 150 
mL). Combined organic layers were washed with brine (300 mL), dried over Na2SO4, 
filtered and concentrated down to give an orange oil. The crude material was left in the 
flask for 36 hours to allow the hydrolysis of anhydride formed under reaction conditions. 
Flash chromatography (0% to 60% EtOAc in hexanes) afforded dipeptide 272 as a pink 
foam (1.81 g, 2.97 mmol, 84% yield). [α]D25 = +18° (c = 1.22, CHCl3); 1H NMR (500 
MHz, DMSO-d6, compound exists as a 1.4 : 1 : 1 mixture of rotamers) complicated 
spectrum, please see the attached 1H NMR spectrum; 13C NMR (126 MHz, DMSO-d6, 
compound exists as a mixture of rotamers) δ 173.0, 171.6, 171.5, 170.8, 170.2, 168.7, 
157.7 (q, JC-F = 36.5 Hz), 157.0 (q, JC-F = 36.3 Hz), 156.6 (q, JC-F = 36.4 Hz), 151.0, 150.6, 
149.6, 149.2, 148.3, 147.2, 135.1, 134.9, 134.6, 134.5, 134.4, 134.3, 134.0, 133.9, 133.0, 
132.5, 129.1, 128.7, 128.6, 128.4, 128.4, 123.1, 122.6, 122.4, 122.0, 121.3, 120.5, 119.0, 
118.7, 118.6, 118.1, 118.0, 117.9, 117.9, 117.1, 117.0, 116.5, 116.3 (q, JC-F = 288.6 Hz), 
116.3 (q, JC-F = 288.6 Hz), 116.3 (app d, JC-F= 287.3 Hz), 111.5, 108.0, 107.9, 107.5, 
107.5, 106.9, 91.1, 89.5, 89.3, 89.1, 87.9, 87.7, 62.2, 61.1, 60.1, 60.0, 58.8, 58.1, 55.7, 
53.2, 53.1, 52.6, 52.0, 50.2, 49.9, 49.5, 49.2, 46.0, 43.4, 42.8, 42.1, 41.6, 41.5, 40.8, 38.5, 
37.7, 37.6, 36.1, 32.8, 26.5, 23.4, 19.4; FTIR (NaCl, thin film): 3075, 3052, 3016, 2954, 
2869, 1744, 1696, 1681, 1638, 1607, 1491, 1448, 1437, 1406, 1357, 1298, 1282, 1210, 
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1184, 1145, 1106, 1022, 992, 922, 847, 742 cm-1; HRMS (APCI) calc’d for C33H36F3N4O4 
[M+H]+ 609.2683, found 609.2683. 
Preparation of bis(allyl)-diketopiperazine 263 
 
To a 200 mL flask was added dipeptide 272 (1.81 g, 2.97 mmol, 1.0 equiv) and it 
was dissolved with THF (50 mL). LiOH (428 mg, 17.84 mmol, 6.0 equiv) was dissolved 
in distilled water (50 mL) and the resulting aqueous solution was added into the reaction 
flask. The reaction was allowed to stir at room temperature for 12 hours. 1M HCl (20 
mL) was then added into the reaction, and the reaction was stirred for another 40 minutes. 
The mixture was extracted with EtOAc (3 x 50 mL). Combined organic layers were 
washed with saturated NaHCO3 (150 mL) and brine (150 mL). It was dried over Na2SO4, 
filtered and concentrated down to give a yellow oil. Flash chromatography (0% to 50% 
EtOAc in hexanes) afforded diketopiperazine 263 as a white solid (1.05 g, 2.18 mmol, 
74% yield). [α]D25 = +90° (c = 1.13, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.14 (app tdd, 
J = 7.8, 6.6, 1.3 Hz, 2H), 7.07 (app ddd, J = 7.0, 5.6, 1.2 Hz, 2H), 6.75 (td, J = 7.5, 1.0 
Hz, 1H), 6.73 (td, J = 7.5, 0.9 Hz, 1H), 6.48 (d, J = 7.9 Hz, 1H), 6.40 (d, J = 7.7 Hz, 1H), 
5.86 (dddd, J = 16.5, 10.4, 6.1, 4.3 Hz, 1H), 5.61 (dddd, J = 16.7, 10.1, 7.9, 6.4 Hz, 1H), 
5.42 (s, 1H), 5.41 (s, 1H), 5.27 (dq, J = 17.1, 1.9 Hz, 1H), 5.13 (dq, J = 10.3, 1.6 Hz, 1H), 
5.11 – 5.08 (m, 1H), 5.07 (q, J = 1.7 Hz, 1H), 4.40 (ddd, J = 9.9, 8.3, 1.5 Hz, 1H), 4.29 
(ddt, J = 16.8, 4.2, 1.9 Hz, 1H), 4.16 (ddd, J = 10.5, 6.7, 1.4 Hz, 1H), 4.09 – 3.98 (m, 
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1H), 3.03 (s, 3H), 2.69 (dd, J = 12.9, 6.7 Hz, 1H), 2.52 (ddt, J = 13.8, 6.5, 1.4 Hz, 1H), 
2.40 (ddt, J = 13.7, 8.0, 1.0 Hz, 1H), 2.36 – 2.29 (m, 3H), 1.45 (s, 3H); 13C NMR (126 
MHz, CDCl3) δ 168.9, 166.3, 150.6, 148.4, 133.9, 133.8, 133.1, 131.3, 128.9, 128.5, 
122.8, 121.3, 118.9, 118.3, 117.9, 116.4, 107.8, 106.1, 87.9, 84.6, 60.8, 59.7, 54.2, 51.0, 
50.8, 42.7, 40.5, 40.4, 33.6, 22.1; FTIR (NaCl, thin film): 3336, 3075, 3053, 3008, 2978, 
2956, 2927, 2891, 2873, 2836, 1676, 1608, 1489, 1465, 1447, 1407, 1335, 1304, 1278, 
1219, 1193, 1160, 1123, 1093, 1050, 1026, 999, 978, 922, 846, 800, 746, 707 cm-1; 
HRMS (MM) calc’d for C30H33N4O2 [M+H]+ 481.2598, found 481.2612. 
Preparation of diketopiperazine 262 
 
To a 25 mL flame-dried screw-cap Schlenk flask was added bis(allyl)-
diketopiperazine 263 (650 mg, 1.35 mmol, 1.0 equiv) and dimethylbibarturic acid 
(DMBA, 634 mg, 4.06 mmol, 3.0 equiv). The Schlenk flask was then evacuated and 
backfilled with argon three times. The solids were then dissolved in dry DCE (3.7 mL). 
In the meantime, in a 1-dram vial, mixed Pd2(dba)3 (62 mg, 0.068 mmol, 5 mol %) and 
1,4-bis(diphenylphosphino)butane (dppb, 58 mg, 0.135 mmol, 10 mol %) in DCE (1.7 
mL) and it was allowed to stir at room temperature for one hour; then the resulting 
solution was added into Schlenk flask. The reaction was heated to 80 °C. After 42 hours, 
the reaction was cooled to room temperature and quenched with saturated Na2CO3 
aqueous solution (40 mL). The mixture was extracted with EtOAc (3 x 40 mL). 
Combined organic layers were washed with brine (100 mL). It was dried over Na2SO4, 
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filtered and concentrated down to give a brown oil. Flash chromatography (0% to 40% 
EtOAc in hexanes) afforded diketopiperazine 262, which was contaminated with 
phosphine oxide formed from the dppb ligand. The mixture was then subjected to 
preparative reverse phase HPLC (40% to 90% CH3CN in H2O in 10 minutes, tR=7.4-7.8 
min), to give pure product 262 as a yellow foam (596 mg, 1.35 mmol, quantitative yield). 
[α]D25 = +71° (c = 0.49, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.14 (td, J = 7.7, 1.3 Hz, 
1H), 7.12 – 7.04 (m, 3H), 6.78 (td, J = 7.4, 1.0 Hz, 1H), 6.72 (td, J = 7.4, 1.0 Hz, 1H), 
6.59 (dt, J = 7.7, 0.8 Hz, 1H), 6.39 (d, J = 7.8 Hz, 1H), 5.56 (dddd, J = 16.8, 10.1, 8.0, 6.5 
Hz, 1H), 5.38 (s, 1H), 5.34 (s, 1H), 5.27 (br s, 1H), 5.08 – 5.04 (m, 1H), 5.03 (dtd, J = 
2.8, 1.8, 1.1 Hz, 1H), 4.44 (ddd, J = 10.1, 7.4, 1.8 Hz, 1H), 4.15 (ddd, J = 10.7, 6.5, 1.8 
Hz, 1H), 3.01 (s, 3H), 2.65 (dd, J = 12.9, 6.5 Hz, 1H), 2.50 (ddt, J = 13.8, 6.6, 1.3 Hz, 
1H), 2.46 – 2.34 (m, 3H), 2.28 (dd, J = 12.9, 10.7 Hz, 1H), 1.47 (s, 3H); 13C NMR (126 
MHz, CDCl3) δ 167.1, 165.8, 150.7, 147.0, 133.3, 133.1, 131.2, 128.8, 128.4, 122.9, 
122.4, 119.2, 118.9, 117.9, 109.3, 106.1, 84.7, 83.7, 60.2, 59.2, 54.1, 51.3, 42.8, 40.7, 
40.2, 33.5, 23.4; FTIR (NaCl, thin film): 3346, 3074, 3052, 3007, 2976, 2955, 2925, 
2896, 2871, 2834, 1666, 1608, 1487, 1468, 1414, 1341, 1300, 1252, 1198, 1161, 1122, 
1091, 1059, 1048, 1018, 1000, 978, 921, 887, 824, 746 cm-1; HRMS (MM) calc’d for 
C27H29N4O2 [M+H]+ 441.2285, found 441.2294. 
Preparation of (+)-nocardioazine B (187) 
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To a 25 mL flame-dried flask was added diketopiperazine 262 (8.4 mg, 0.019 
mmol, 1.0 equiv), which was then co-evaporated with benzene (2 x 1 mL), and dried 
under high vacuum. Hoveyda-Grubbs II catalyst (1.2 mg, 0.002 mmol, 10 mol %) was 
added, followed by 2-methyl-2-butene (4.5 mL). The flask was equipped with a 
condenser and heated to 38 °C for 10 hours. The reaction was then quenched with ethyl 
vinyl ether (0.1 mL) and filtered through a silica gel plug, eluting with 50% EtOAc in 
hexanes. The filtrate was concentrated down to give a light brown oil. Flash 
chromatography (5% to 50% EtOAc in hexanes) afforded (+)-nocardioazine B (187) as a 
light grey solid (7.4 mg, 0.016 mmol, 83% yield). [α]D25 = +65° (c = 0.36, CHCl3); 1H 
NMR (500 MHz, CDCl3) δ 7.16 – 7.09 (m, 2H), 7.09 (td, J = 7.7, 1.2 Hz, 1H), 7.04 (dd, J 
= 7.3, 1.2 Hz, 1H), 6.78 (td, J = 7.4, 1.0 Hz, 1H), 6.71 (td, J = 7.4, 1.0 Hz, 1H), 6.59 (d, J 
= 7.7 Hz, 1H), 6.39 (d, J = 7.8 Hz, 1H), 5.35 (s, 1H), 5.31 (s, 1H), 5.21 (br s, 1H), 5.00 
(tq, J = 4.9, 1.6 Hz, 1H), 4.44 (ddd, J = 9.8, 7.7, 1.8 Hz, 1H), 4.15 (ddd, J = 10.7, 6.5, 1.8 
Hz, 1H), 3.01 (s, 3H), 2.64 (dd, J = 12.8, 6.5 Hz, 1H), 2.47 – 2.32 (m, 4H), 2.28 (dd, J = 
12.8, 10.7 Hz, 1H), 1.65 (s, 3H), 1.50 (s, 3H), 1.47 (s, 3H); 13C NMR (126 MHz, CDCl3) 
δ 167.3, 165.9, 150.6, 147.1, 135.5, 133.4, 131.9, 128.7, 128.5, 122.8, 122.4, 119.3, 
118.6, 118.0, 109.3, 106.2, 84.9, 83.7, 60.4, 59.3, 54.7, 51.3, 40.9, 39.6, 36.5, 33.6, 25.9, 
23.4, 18.0; FTIR (NaCl, thin film): 3348, 3051, 2956, 2925, 2870, 2855, 1667, 1608, 
1487, 1468, 1445, 1415, 1381, 1342, 1301, 1261, 1232, 1200, 1156, 1099, 1085, 1065, 
1042, 1019, 1000, 976, 942, 890, 850, 822, 802, 781, 744 cm-1; HRMS (MM) calc’d for 
C29H33N4O2 [M+H]+ 469.2598, found 469.2604. 
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Table 3.2. Comparison of 1H NMR data for natural vs. synthetic (+)-nocardioazine 
B (187) 
 
Raju et al. Report,3 
Natural 
(+)-nocardioazine B 
1H NMR, 600 MHz, CDCl3 
This Work, 
Synthetic 
(+)-nocardioazine B 
1H NMR, 500 MHz, CDCl3 
δ 7.11 (ddd, J = 7.7, 7.4, 1.1 Hz, 1H) δ 7.16 – 7.09 (m, 2H) 
7.08 (ddd, J = 7.7, 7.4, 1.0 Hz, 1H) - 
7.06 (dd, J = 7.4, 1.0 Hz, 1H) 7.09 (td, J = 7.7, 1.2 Hz, 1H) 
7.02 (dd, J = 7.4, 1.1 Hz, 1H) 7.04 (dd, J = 7.3, 1.2 Hz, 1H) 
6.75 (ddd, J = 7.4, 7.4, 0.9 Hz, 1H) 6.78 (td, J = 7.4, 1.0 Hz, 1H) 
6.69 (ddd, J = 7.4, 7.4, 0.9 Hz, 1H) 6.71 (td, J = 7.4, 1.0 Hz, 1H) 
6.57 (dd, J = 7.7, 0.9 Hz, 1H) 6.59 (d, J = 7.7 Hz, 1H) 
6.38 (dd, J = 7.7, 0.9 Hz, 1H) 6.39 (d, J = 7.8 Hz, 1H) 
5.33 (s, 1H) 5.35 (s, 1H) 
5.29 (s, 1H) 5.31 (s, 1H) 
5.18 (s, 1H) 5.21 (br s, 1H) 
4.98 (m, 1H) 5.00 (tq, J = 4.9, 1.6 Hz, 1H) 
4.42 (ddd, J = 9.8, 7.6, 1.8 Hz, 1H) 4.44 (ddd, J = 9.8, 7.7, 1.8 Hz, 1H) 
4.13 (ddd, J = 10.7, 6.5, 1.7 Hz, 1H) 4.15 (ddd, J = 10.7, 6.5, 1.8 Hz, 1H) 
2.99 (s, 3H) 3.01 (s, 3H) 
2.62 (dd, J = 12.9, 6.5 Hz, 1H) 2.64 (dd, J = 12.8, 6.5 Hz, 1H) 
2.37 (m, 2H) 2.47 – 2.32 (m, 4H) 
2.35 (m, 2H) – 
2.25 (dd, J = 12.9, 10.7 Hz, 1H) 2.28 (dd, J = 12.8, 10.7 Hz, 1H) 
1.63 (s, 3H) 1.65 (s, 3H) 
1.48 (s, 3H) 1.50 (s, 3H) 
1.45 (s, 3H) 1.47 (s, 3H) 
 
Table 3.3. Comparison of 13C NMR data for natural vs. synthetic (+)-nocardioazine 
B (187) 
 
Raju et al. Report,3 
Natural 
(+)-nocardioazine B 
13C NMR, 150 MHz, CDCl3 
This Work, 
Synthetic 
(+)-nocardioazine B 
13C NMR, 126 MHz, CDCl3 
Chemical Shift Difference, Δδ 
δ 167.1 δ 167.3 0.2 
NR 165.9 – 
150.6 150.6 0.0 
146.9 147.1 0.2 
135.5 135.5 0.0 
133.3 133.4 0.1 
132.0 131.9 0.1 
128.8 128.7 0.1 
128.5 128.5 0.0 
122.8 122.8 0.0 
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122.4 122.4 0.0 
119.2 119.3 0.1 
118.6 118.6 0.0 
117.9 118.0 0.1 
109.4 109.3 0.1 
106.2 106.2 0.0 
85.0 84.9 0.1 
83.7 83.7 0.0 
60.4 60.4 0.0 
59.3 59.3 0.0 
54.6 54.7 0.1 
51.2 51.3 0.1 
41.0 40.9 0.1 
39.8 39.6 0.2 
36.7 36.5 0.2 
33.7 33.6 0.1 
26.0 25.9 0.1 
23.4 23.4 0.0 
17.9 18.0 0.1 
 
Preparation of enal 275 
 
To a 50 mL flame-dried flask was added diketopiperazine 262 (431 mg, 0.98 
mmol, 1.0 equiv) and DCM (9 mL), followed by methacrolein 274 (95%, 0.85 mL, 9.78 
mmol, 10 equiv). ortho-iPr-Hoveyda-Grubbs II catalyst (61.3 mg, 0.10 mmol, 10 mol %) 
was added as a DCM solution (0.1 mL) at last. The flask was equipped with a condenser 
and heated to 40 °C for 18 hours. The reaction was then quenched with ethyl vinyl ether 
(0.5 mL) and filtered through a silica gel plug, eluting with EtOAc. The filtrate was 
concentrated down to give a brown oil. Flash chromatography (10% to 80% EtOAc in 
hexanes) afforded enal 275 as a light grey foam (E : Z = 10 : 1 mixture, 356 mg, 0.74 
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mmol, 76% yield). The mixture of isomers was further purified by flash chromatography 
(10% to 80% EtOAc in hexanes) to give (E)-275 for characterization purposes. [α]D25 = 
+77° (c = 0.96, CHCl3); 1H NMR (300 MHz, CDCl3) δ 9.30 (s, 1H), 7.17 (td, J = 7.5, 1.2 
Hz, 1H), 7.13 – 7.02 (m, 3H), 6.82 – 6.71 (m, 2H), 6.60 (d, J = 7.5 Hz, 1H), 6.42 (d, J = 
7.9 Hz, 1H), 6.25 (ddd, J = 8.7, 6.7, 1.5 Hz, 1H), 5.38 (s, 1H), 5.35 (s, 1H), 5.20 (br s, 
1H), 4.47 (ddd, J = 9.7, 8.0, 1.8 Hz, 1H), 4.19 (ddd, J = 10.7, 6.5, 1.9 Hz, 1H), 3.01 (s, 
3H), 2.83 – 2.71 (m, 3H), 2.41 (d, J = 2.4 Hz, 1H), 2.38 (s, 1H), 2.32 (dd, J = 12.8, 10.6 
Hz, 1H), 1.66 – 1.65 (m, 3H), 1.47 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 194.6, 166.7, 
165.8, 150.4, 147.6, 146.9, 141.6, 133.2, 130.0, 129.3, 128.4, 122.5, 122.3, 119.2, 118.2, 
109.3, 106.3, 84.7, 83.6, 60.2, 59.1, 53.7, 51.2, 40.7, 40.3, 37.3, 33.1, 23.2, 9.4; FTIR 
(NaCl, thin film): 3351, 3051, 3013, 2953, 2929, 2872, 2716, 1670, 1607, 1486, 1468, 
1446, 1412, 1339, 1302, 1262, 1235, 1200, 1157, 1126, 1099, 1083, 1040, 1019, 1000, 
978, 932, 883, 809, 747 cm-1; HRMS (MM) calc’d for C29H31N4O3 [M+H]+ 483.2391, 
found 483.2410. 
Preparation of allylic alcohol 261 
 
To a 50 mL flask was added aldehyde 275 (E : Z = 10 : 1 mixture, 159 mg, 0.33 
mmol, 1.0 equiv) and methanol (12 mL). Sonicator was used to facilitate 275 to dissolve 
in solution. Then, cerium chloride heptahydrate (307 mg, 0.82 mmol, 2.5 equiv) was 
dissolved in methanol (2 mL), while NaBH4 (25 mg, 0.66 mmol, 2.0 equiv) was dissolved 
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in methanol (2 mL). The reaction was cooled to 0 °C. The previously prepared methanol 
solution of cerium chloride was added into the reaction flask, quickly followed by the 
addition of NaBH4 methanol solution. After reacting at 0 °C for 40 minutes, the reaction 
was quenched with saturated ammonium chloride solution (30 mL), followed by EtOAc 
(30 mL). The mixture was separated and aqueous layer was extracted with EtOAc (3 x 30 
mL). Combined organic layers were washed with brine (50 mL), dried over Na2SO4, 
filtered, and concentrated down to give a grey oil. Flash chromatography (20% to 90% 
EtOAc in hexanes) afforded allylic alcohol 261 as a white foam (133 mg, 0.27 mmol, 
84% yield). [α]D25 = +68° (c = 0.51, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.13 (td, J = 
7.7, 1.3 Hz, 1H), 7.11 – 7.06 (m, 2H), 7.05 (dd, J = 7.4, 1.2 Hz, 1H), 6.78 (td, J = 7.4, 1.0 
Hz, 1H), 6.71 (td, J = 7.4, 1.0 Hz, 1H), 6.59 (dt, J = 7.6, 0.8 Hz, 1H), 6.40 (d, J = 7.8 Hz, 
1H), 5.36 (s, 1H), 5.35 (br s, 2H), 5.29 (ddt, J = 9.5, 6.7, 1.5 Hz, 1H), 4.44 (ddd, J = 9.9, 
8.4, 1.8 Hz, 1H), 4.16 (ddd, J = 10.1, 7.0, 1.8 Hz, 1H), 3.90 (s, 2H), 3.00 (s, 3H), 2.61 
(dd, J = 13.0, 7.0 Hz, 1H), 2.51 – 2.39 (m, 2H), 2.39 – 2.30 (m, 3H), 2.15 (s, 1H), 1.56 (s, 
3H), 1.46 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 167.2, 165.8, 150.4, 147.0, 138.8, 
133.3, 131.8, 128.8, 128.4, 122.6, 122.3, 119.3, 119.2, 118.0, 109.5, 106.2, 85.2, 83.6, 
68.2, 60.3, 59.3, 54.2, 51.3, 40.8, 39.4, 35.9, 33.5, 23.2, 13.9; FTIR (NaCl, thin film): 
3367, 3051, 3004, 2929, 2872, 1664, 1607, 1486, 1468, 1420, 1341, 1301, 1251, 1199, 
1155, 1099, 1085, 1065, 1039, 1018, 1002, 978, 943, 892, 824, 746 cm-1; HRMS (MM) 
calc’d for C29H33N4O3 [M+H]+ 485.2547, found 485.2554. 
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Preparation of allylic chloride 276 
 
To a 10 mL flame-dried flask was added allylic alcohol 261 (60 mg, 0.12 mmol, 
1.0 equiv) and THF (1.2 mL). The reaction was cooled to 0 °C. Mesyl chloride (MsCl, 11 
µL, 0.14 mmol, 1.1 equiv) was added into the reaction solution, followed by Et3N (35 µL, 
0.25 mmol, 2.0 equiv). After 1.5 hours, the reaction was filtered through a plug of 
Kimwipes and washed with THF. The filtrate was concentrated down and co-evaporated 
with benzene. The crude material was re-dissolved in THF (1 mL), and LiOH (52.5 mg, 
1.24 mmol, 10 equiv) in THF (0.2 mL) was transferred into the reaction flask. The 
resulting white slurry was allowed to stir at room temperature for 1.5 hours before it was 
quenched with saturated NaHCO3 (10 mL). The mixture was extracted with EtOAc (3 x 
10 mL). Combined organic layers were washed with brine (30 mL), dried over Na2SO4, 
filtered, and concentrated down to give a yellow liquid. Flash chromatography (10% to 
50% EtOAc in hexanes) afforded allylic chloride 276 as a light yellow foam (55 mg, 0.11 
mmol, 89% yield). [α]D25 = +68° (c = 1.30, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.14 
(td, J = 7.6, 1.3 Hz, 1H), 7.12 – 7.06 (m, 2H), 7.05 (dd, J = 7.4, 1.2 Hz, 1H), 6.78 (td, J = 
7.4, 1.0 Hz, 1H), 6.72 (td, J = 7.4, 1.0 Hz, 1H), 6.60 (dt, J = 7.7, 0.8 Hz, 1H), 6.40 (d, J = 
7.8 Hz, 1H), 5.36 (t, J = 6.8 Hz, 1H), 5.35 (s, 1H), 5.31 (s, 1H), 5.23 (br s, 1H), 4.45 
(ddd, J = 9.7, 8.1, 1.8 Hz, 1H), 4.16 (ddd, J = 10.6, 6.5, 1.8 Hz, 1H), 3.98 – 3.87 (m, 2H), 
3.01 (s, 3H), 2.69 (dd, J = 12.8, 6.5 Hz, 1H), 2.45 (d, J = 7.5 Hz, 2H), 2.42 – 2.35 (m, 
2H), 2.27 (dd, J = 12.8, 10.6 Hz, 1H), 1.63 (s, 3H), 1.47 (s, 3H); 13C NMR (126 MHz, 
MsCl, Et3N
THF, 23 °C;
then LiCl
THF, 23 °C
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CDCl3) δ 167.1, 165.9, 150.5, 147.0, 135.3, 133.3, 130.9, 129.0, 128.5, 124.7, 122.9, 
122.4, 119.3, 118.1, 109.4, 106.2, 85.0, 83.7, 60.3, 59.2, 54.2, 51.8, 51.3, 40.9, 40.0, 36.6, 
33.5, 23.4, 14.5; FTIR (NaCl, thin film): 3345, 3051, 3006, 2954, 2928, 2871, 1667, 
1607, 1486, 1468, 1414, 1341, 1302, 1262, 1199, 1157, 1110, 1100, 1083, 1062, 1019, 
1001, 977, 932, 746 cm-1; HRMS (MM) calc’d for C29H32ClN4O2 [M+H]+ 503.2208, 
found 503.2221. 
Preparation of macrocyclic alkene 277 
 
To a 25 mL flame-dried Schlenk flask with a screw cap was added allylic chloride 
276 (20 mg, 0.04 mmol, 1.0 equiv), tetra-n-butylammonium iodide (TBAI, 294 mg, 0.80 
mmol, 20.0 equiv), and acetonitrile (4 mL). DIPEA (8.3 µL, 0.048 mmol, 1.2 equiv) was 
added at last from freshly prepared DIPEA stock solution. The Schlenk flask was sealed 
and heated to 80 °C for 24 hours. It was then cooled to room temperature and quenched 
with saturated NaHCO3 aqueous solution (20 mL). The mixture was extracted with 
EtOAc (3 x 15 mL). Combined organic layers were washed with brine (30 mL), dried 
over Na2SO4, filtered and concentrated down to give a yellow liquid. Flash 
chromatography (5% to 50% EtOAc in hexanes) afforded macrocyclic alkene 277 as a 
white solid (13.5 mg, 0.029 mmol, 73% yield). [α]D25 = +45° (c = 0.47, CHCl3); 1H NMR 
(500 MHz, CD3CN) δ 7.16 – 7.09 (m, 3H), 7.07 (td, J = 7.7, 1.4 Hz, 1H), 6.72 (td, J = 
7.5, 1.0 Hz, 1H), 6.65 (t, J = 7.4 Hz, 1H), 6.52 (d, J = 7.7 Hz, 1H), 6.46 (d, J = 7.9 Hz, 
1H), 5.51 (s, 1H), 5.48 (s, 1H), 5.28 (br s, 1H), 4.57 (t, J = 8.8 Hz, 1H), 4.37 (d, J = 10.7 
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Hz, 1H), 4.02 (d, J = 16.1 Hz, 1H), 3.47 (d, J = 16.1 Hz, 1H), 2.89 (br s, 1H), 2.83 (s, 
3H), 2.42 – 2.22 (m, 3H), 1.55 (s, 3H), 1.47 (s, 3H); 13C NMR (126 MHz, CDCl3) 149.3, 
128.6, 128.6, 121.7, 121.4, 118.5, 110.0, 107.7, 91.9, 61.9, 59.2, 53.0, 34.0 (Presumably, 
at room temperature, the alkene in macrocyclic olefin 277 quickly underwent rotation, 
resulting in 1H NMR signals broadening and not all carbon signals showing up); 1H NMR 
(500 MHz, CD3CN, 70 °C) δ 7.17 – 7.10 (m, 3H), 7.09 (td, J = 7.8, 1.4 Hz, 1H), 6.73 (td, 
J = 7.4, 1.0 Hz, 1H), 6.67 (td, J = 7.4, 1.0 Hz, 1H), 6.52 (d, J = 7.7 Hz, 1H), 6.46 (d, J = 
7.9 Hz, 1H), 5.51 (s, 1H), 5.49 (s, 1H), 5.30 (t, J = 8.4 Hz, 1H), 4.58 (t, J = 8.7 Hz, 1H), 
4.38 (dd, J = 11.2, 2.3 Hz, 1H), 4.03 (d, J = 16.3 Hz, 1H), 3.52 (d, J = 16.3 Hz, 1H), 2.92 
(d, J = 13.9 Hz, 1H), 2.90 – 2.82 (m, 1H), 2.86 (s, 3H), 2.41 (dd, J = 13.4, 8.8 Hz, 1H), 
2.34 (d, J = 8.8 Hz, 1H), 2.30 (dd, J = 11.0, 7.0 Hz, 1H), 2.19 (dd, J = 13.7, 11.3 Hz, 1H), 
1.60 (s, 3H), 1.50 (s, 3H); 13C NMR (126 MHz, CD3CN, 70 °C) δ 171.8, 170.5, 151.0, 
149.5, 138.3, 136.1, 135.5, 129.7, 123.0, 122.9, 122.8, 122.7, 119.5, 118.7, 108.6, 108.6, 
106.6, 106.5, 92.9, 92.9, 90.3, 63.2, 60.3, 60.3, 56.4, 54.3, 52.3, 41.9, 39.5, 34.7, 34.5, 
34.4, 21.7, 15.2; FTIR (NaCl, thin film): 3051, 3008, 2954, 2923, 2870, 2856, 1670, 
1609, 1485, 1465, 1450, 1429, 1391, 1348, 1304, 1259, 1216, 1186, 1156, 1142, 1122, 
1096, 1065, 1023, 1001, 978, 921, 881, 789, 742 cm-1; HRMS (MM) calc’d for 
C29H31N4O2 [M+H]+ 467.2442, found 467.2450. 
Preparation of N-oxide 278 
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To a 0.5-dram vial was transferred macrocyclic olefin 277 (2.2 mg, 0.0047 mmol, 
1.0 equiv), which was dissolved in acetone (0.35 mL). The reaction was cooled to 0 °C. 
Freshly prepared DMDO acetone solution (0.050 M, 104 µL, 0.0052 mmol, 1.1 equiv) 
was added. The reaction was allowed to stir for 15 minutes before being concentrated 
down to give a light yellow solid. Preparative thin layer chromatography (10% MeOH in 
DCM) afforded N-oxide 278 as a white solid (1.2 mg, 0.0025 mmol, 53% yield); starting 
material 277 was also isolated (0.8 mg). [α]D25 = +78° (c = 0.12, CH2Cl2); 1H NMR (500 
MHz, CD2Cl2) δ 7.54 – 7.49 (m, 1H), 7.49 – 7.42 (m, 2H), 7.42 – 7.34 (m, 1H), 7.09 (app 
ddd, J = 7.3, 4.4, 3.0 Hz, 2H), 6.69 (t, J = 7.4 Hz, 1H), 6.40 (d, J = 8.1 Hz, 1H), 5.75 (s, 
1H), 5.56 (s, 1H), 4.99 – 4.82 (m, 1H), 4.68 (t, J = 8.8 Hz, 1H), 4.00 (d, J = 16.5 Hz, 1H), 
3.62 (s, 3H), 3.58 (d, J = 16.5 Hz, 1H), 2.89 (br s, 1H), 2.72 (t, J = 11.9 Hz, 1H), 2.59 – 
2.49 (m, 1H), 2.37 (t, J = 11.4 Hz, 1H), 2.28 (br s, 1H), 1.86 (br s, 4H), 1.52 (s, 3H); 13C 
NMR (126 MHz, CD2Cl2) δ 70.2, 138.0, 130.5, 130.0, 129.0, 124.4, 122.1, 117.6, 99.1, 
66.5, 59.6, 56.4, 52.5, 51.6, 41.1 (Presumably, at room temperature, the alkene in 
macrocyclic olefin 278 quickly underwent rotation, resulting in 1H NMR signals 
broadening and not all carbon signals showing up); FTIR (NaCl, thin film): 3047, 2955, 
2907, 1681, 1607, 1482, 1449, 1432, 1388, 1305, 1270, 1225, 1201, 1156, 1142, 1119, 
1094, 1064, 1050, 1022, 1004, 962, 932, 917, 884, 832, 816, 805, 780, 741 cm-1; HRMS 
(MM) calc’d for C29H31N4O3 [M+H]+ 483.2391, found 483.2388. 
Preparation of diol 279 
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To a 0.5-dram vial was added K3Fe(CN)6 (10.4 mg, 0.032 mmol, 3.0 equiv), 
K2CO3 (4.5 mg, 0.033 mmol, 3.1 equiv) and K2OsO4•2H2O (1.2 mg, 0.003 mmol, 30 mol 
%), followed by addition of distilled water (240 µL) and methanesulfonamide (3.0 mg, 
0.032mmol, 3.0 equiv). 1,4-Diazabicyclooctane (DABCO, 0.6 mg, 0.005 mmol, 0.5 
equiv) was added as a t-butanol solution (10 µL). At last, macrocyclic alkene 277 (4.8 
mg, 0.010 mmol, 1.0 equiv) was added as tert-butanol solution (240 µL; additional heat 
was required to increase the solubility of 277 in tert-butanol; there is a small time 
window where 277 is completely soluble in tert-butanol after it cools down to room 
temperature, which marks the time to add it to the reaction flask). The reaction turned 
into a brown homogeneous solution, which was stirred for 12 hours. It was then quenched 
with solid Na2SO3, followed by addition of 2N KOH (0.5 mL). It was stirred for another 
two hours before it was diluted with EtOAc (2 mL). The mixture was separated and the 
aqueous layer was extracted with EtOAc (3 x 2 mL). Combined organic layers were 
washed with brine (3 mL), dried over Na2SO4, filtered, and concentrated down to give a 
white solid. Flash chromatography (5% to 50% EtOAc in hexanes) afforded diol 279 as a 
white solid (3.9 mg, 0.008 mmol, 76% yield). [α]D25 = +36° (c = 0.33, CHCl3); 1H NMR 
(500 MHz, CDCl3) δ 7.14 (tt, J = 7.7, 1.5 Hz, 2H), 7.08 (ddd, J = 7.4, 2.4, 1.2 Hz, 2H), 
6.89 (d, J = 7.9 Hz, 1H), 6.82 (td, J = 7.4, 0.9 Hz, 1H), 6.79 (td, J = 7.5, 1.0 Hz, 1H), 6.52 
(d, J = 7.7 Hz, 1H), 5.77 (s, 1H), 5.65 (s, 1H), 4.60 (dd, J = 10.0, 8.1 Hz, 1H), 4.47 (d, J 
= 8.7 Hz, 1H), 3.52 (d, J = 15.4 Hz, 1H), 3.31 (d, J = 15.4 Hz, 1H), 3.25 (d, J = 10.5 Hz, 
1H), 2.96 (d, J = 12.6 Hz, 1H), 2.92 (s, 3H), 2.75 (dd, J = 13.4, 10.1 Hz, 1H), 2.49 (dd, J 
= 12.7, 8.8 Hz, 1H), 2.48 (s, 1H), 2.27 (dd, J = 13.4, 8.1 Hz, 1H), 2.17 (dd, J = 15.5, 10.5 
Hz, 1H), 1.99 (d, J = 15.6 Hz, 1H), 1.86 (s, 1H), 1.49 (s, 3H), 1.09 (s, 3H); 13C NMR 
134
Chapter 3 – Enantioselective Total Synthesis of (+)-Nocardioazines A and B  
(126 MHz, CDCl3) δ 171.9, 170.8, 149.3, 148.8, 134.5, 133.3, 128.6, 128.3, 121.5, 119.6, 
119.0, 108.7, 108.2, 91.4, 89.4, 76.7, 69.5, 62.3, 60.2, 56.3, 50.6, 50.4, 42.7, 38.6, 35.5, 
34.1, 20.7, 18.3; FTIR (NaCl, thin film): 3518, 3447, 3049, 3010, 2953, 2937, 2894, 
2794, 1670, 1610, 1481, 1448, 1425, 1391, 1349, 1312, 1299, 1274, 1209, 1194, 1167, 
1123, 1091, 1064, 1039, 1021, 1001, 975, 940, 909, 893, 862, 832, 804, 789, 780, 752, 
746, 718 cm-1; HRMS (MM) calc’d for C29H33N4O4 [M+H]+ 501.2496, found 501.2508. 
Preparation of mono-mesylate A-5 
 
To a flame-dried 0.5-dram vial was added diol 279 (6.9 mg, 0.014 mmol, 1.0 
equiv) and THF (0.2 mL). The reaction flask was cooled to 0 °C. Mesyl chloride (MsCl, 
5.5 µL, 0.069 mmol, 5.0 equiv) was added into the reaction solution, followed by Et3N 
(11.5 µL, 0.083 mmol, 6.0 equiv). After 40 minutes, the reaction was quenched with 
saturated NaHCO3 (4 mL). The mixture was extracted with EtOAc (3 x 4 mL). Combined 
organic layers were washed with brine (8 mL), dried over Na2SO4, filtered, and 
concentrated down to give a yellow liquid. Preparative TLC chromatography (60% 
EtOAc in hexanes) afforded mono-mesylate A-5 as a white solid (5.8 mg, 0.10 mmol, 
75% yield). [α]D25 = +67° (c = 0.45, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.16 (td, J = 
7.7, 1.2 Hz, 1H), 7.14 (td, J = 7.9, 1.3 Hz, 1H), 7.07 (ddd, J = 8.8, 7.4, 1.3 Hz, 2H), 7.00 
(d, J = 7.9 Hz, 1H), 6.85 (td, J = 7.4, 1.0 Hz, 1H), 6.79 (td, J = 7.5, 1.0 Hz, 1H), 6.53 (d, 
J = 7.8 Hz, 1H), 5.83 (s, 1H), 5.62 (s, 1H), 4.61 (dd, J = 10.2, 8.0 Hz, 1H), 4.58 (d, J = 
10.7 Hz, 1H), 4.46 (d, J = 8.5 Hz, 1H), 3.52 (d, J = 15.5 Hz, 1H), 3.33 (d, J = 15.5 Hz, 
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1H), 2.96 (s, 3H), 2.94 (d, J = 12.7 Hz, 1H), 2.83 (dd, J = 13.4, 10.2 Hz, 1H), 2.74 (s, 
3H), 2.53 (dd, J = 12.7, 8.6 Hz, 1H), 2.49 (dd, J = 16.8, 10.8 Hz, 1H), 2.40 (s, 1H), 2.30 
(dd, J = 13.4, 7.9 Hz, 1H), 2.13 (d, J = 16.8 Hz, 1H), 1.48 (s, 3H), 1.16 (s, 3H); 13C NMR 
(126 MHz, CDCl3) δ 171.8, 171.7, 149.5, 149.2, 133.3, 132.7, 128.7, 128.6, 121.5, 121.3, 
120.0, 118.8, 109.8, 108.4, 90.7, 89.7, 83.5, 76.6, 62.1, 60.5, 57.9, 50.5, 50.3, 42.8, 38.9, 
38.6, 34.1, 33.1, 20.6, 18.8; FTIR (NaCl, thin film): 3541, 3390, 3024, 2954, 2925, 2855, 
2798, 1694, 1674, 1610, 1482, 1447, 1427, 1379, 1347, 1337, 1301, 1273, 1198, 1171, 
1124, 1091, 1062, 1028, 1000, 974, 957, 944, 933, 916, 895, 851, 835, 806, 781, 752 cm-
1; HRMS (MM) calc’d for C30H35N4O6S [M+H]+ 579.2272, found 579.2278. 
Preparation of epi-(C2”)-nocardioazine A (280) 
 
To a flame-dried 1-dram vial was added mono-mesylate A-5 (4.0 mg, 0.007 
mmol, 1.0 equiv) and K2CO3 (12.6 mg, 0.091 mmol, 13.0 equiv). Methanol (0.9 mL) was 
added at last. The vial was sealed using a Teflon cap and heated to 50 °C for 90 minutes. 
The reaction was cooled to room temperature and quenched with saturated NaHCO3 (4 
mL). The mixture was extracted with EtOAc (3 x 4 mL). Combined organic layers were 
washed with brine (8 mL), dried over Na2SO4, filtered, and concentrated down to give a 
white liquid. Flash chromatography (10% to 50% EtOAc in hexanes) afforded epi-(C2”)-
nocardioazine A (280) as a white solid, which was contaminated with an unknown side 
product as a 10 : 1 mixture detected by 1H NMR, (corrected yield: 2.9 mg, 0.0060 mmol, 
87% yield). [α]D25 = +36° (c = 0.33, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.20 (td, J = 
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7.7, 1.3 Hz, 1H), 7.10 (td, J = 7.7, 1.2 Hz, 1H), 7.11 (dd, J = 7.5, 1.3 Hz, 1H), 7.06 (dd, J 
= 7.3, 1.3 Hz, 1H), 6.79 (td, J = 7.5, 1.0 Hz, 1H), 6.66 (td, J = 7.4, 0.9 Hz, 1H), 6.53 (d, J 
= 7.8 Hz, 1H), 6.49 (d, J = 7.8 Hz, 1H), 5.75 (s, 1H), 5.73 (s, 1H), 4.51 (dd, J = 10.6, 7.6 
Hz, 1H), 4.40 (d, J = 8.6 Hz, 1H), 3.59 (d, J = 15.6 Hz, 1H), 3.37 (d, J = 15.7 Hz, 1H), 
2.95 (s, 3H), 2.91 (d, J = 12.6 Hz, 1H), 2.83 (dd, J = 11.6, 3.7 Hz, 1H), 2.77 (dd, J = 13.2, 
10.7 Hz, 1H), 2.66 (dd, J = 16.0, 3.7 Hz, 1H), 2.45 (dd, J = 12.7, 8.7 Hz, 1H), 2.25 (dd, J 
= 13.1, 7.6 Hz, 1H), 2.00 (dd, J = 16.0, 11.6 Hz, 1H), 1.45 (s, 3H), 1.39 (s, 3H); 13C NMR 
(126 MHz, CDCl3) δ 172.5, 171.4, 149.7, 147.1, 132.9, 132.1, 128.8, 128.3, 121.7, 121.5, 
118.3, 116.9, 108.0, 105.7, 92.9, 86.8, 64.2, 62.2, 61.7, 60.0, 52.0, 50.7, 45.0, 42.1, 39.5, 
33.9, 30.3, 26.1, 19.5; FTIR (NaCl, thin film): 3051, 3009, 2956, 2927, 2893, 2869, 2821, 
2791, 1692, 1671, 1610, 1484, 1467, 1452, 1440, 1425, 1382, 1353, 1301, 1282, 1266, 
1235, 1214, 1197, 1172, 1158, 1144, 1123, 1115, 1093, 1073, 1055, 1048, 1035, 1020, 
991, 973, 958, 945, 924, 892, 881, 859, 847, 830, 801, 792, 780, 751, 742 cm-1; HRMS 
(MM) calc’d for C29H31N4O3 [M+H]+ 483.2391, found 483.2387. 
Preparation of epoxide 281 
 
To a flame-dried 10 mL flask was added Ti(OiPr)4 (3.7 µL, 0.012 mmol, 10 mol 
%), activated 4Å molecular sieves and DCM (2 mL). The reaction flask was cooled to –
20 °C (crushed ice mixed with NaCl at about 3 : 1 ratio). (+)-Diethyl-tartrate (2.5 µL, 
0.015 mmol, 12 mol %) was added. After stirring for 5 minutes, allylic alcohol 261 (60 
mg, 0.124 mmol, 1.0 equiv) was added as a DCM solution (0.5 mL). After 30 minutes, 
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tBuOOH (5.0-6.0 M decane solution, 68 µL, 0.371 mmol, 3.0 equiv) was added. In 105 
minutes, the flask was warmed to 0 °C using an ice water bath. The reaction was 
quenched with freshly prepared and ice-cold FeSO4/citric acid solution (0.66 g FeSO4, 
0.22 g citric acid monohydrate, 2 mL distilled water). The mixture was extracted with 
Et2O (5 x 5 mL). Combined organic layers were cooled to 0 °C and then treated with 
precooled 30% NaOH (w/v) in saturated NaCl solution (prepared using 10 g NaOH, 1.7 g 
NaCl, 30 ml distilled water). The mixture was stirred vigorously for 1 hour. Then two 
layers were separated and the aqueous layer was extracted with Et2O (2 x 30 mL). 
Combined organic layers were dried over MgSO4, filtered, and concentrated down to give 
a colorless oil. Flash chromatography (20% to 95% EtOAc in hexanes) afforded epoxy 
alcohol 281 (10 : 1 mixture of epoxide diastereomers by 1H NMR),  as a white foam (56.5 
mg, 0.113 mmol, 90% yield). [α]D25 = +74° (c = 0.26, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ 7.14 (td, J = 7.6, 1.2 Hz, 1H), 7.07 (app dd, J = 8.0, 6.9 Hz, 3H), 6.79 – 6.74 
(m, 1H), 6.72 (td, J = 7.5, 1.0 Hz, 1H), 6.57 (dt, J = 7.5, 1.0 Hz, 1H), 6.40 (d, J = 7.8 Hz, 
1H), 5.59 (s, 1H), 5.34 (s, 1H), 5.28 (s, 1H), 4.44 (ddd, J = 9.9, 8.1, 1.9 Hz, 1H), 4.14 
(ddd, J = 10.8, 6.3, 1.9 Hz, 1H), 3.41 (d, J = 12.2 Hz, 1H), 3.30 (d, J = 12.3 Hz, 1H), 3.04 
(s, 3H), 2.83 – 2.71 (m, 2H), 2.42 – 2.34 (m, 2H), 2.31 (dd, J = 12.8, 10.9 Hz, 1H), 2.11 
(dd, J = 14.4, 4.9 Hz, 1H), 1.87 (dd, J = 14.4, 7.0 Hz, 1H), 1.46 (s, 3H), 1.12 (s, 3H); 13C 
NMR (101 MHz, CDCl3) δ 167.0, 165.7, 150.8, 147.0, 133.3, 130.2, 129.3, 128.4, 122.8, 
122.3, 119.2, 118.1, 109.4, 106.2, 84.5, 83.7, 65.3, 60.2, 59.8, 59.2, 56.6, 53.1, 51.2, 41.0, 
40.9, 37.1, 33.5, 23.3, 14.3; FTIR (NaCl, thin film): 3354, 3052, 3006, 2956, 2928, 2870, 
1668, 1608, 1486, 1471, 1418, 1339, 1302, 1253, 1197, 1161, 1092, 1036, 1001, 978, 
894, 748 cm-1; HRMS (MM) calc’d for C29H33N4O4 [M+H]+ 501.2496, found 501.2500. 
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Preparation of mesylate 282 
 
To a half-a-dram vial was added alcohol 281 (7 mg, 0.014 mmol, 1.0 equiv), 
which was co-evaporated with benzene (0.4 mL) and dried in vacuo. Under N2, alcohol 
281 was dissolved in THF (0.1 mL) and cooled to 0 °C, when MsCl (1.2 µL, 0.015 
mmol, 1.1 equiv) and Et3N (3.9 µL, 0.028 mmol, 2.0 equiv) were added in sequence as a 
freshly prepared THF stock solution. The reaction mixture was allowed to stir at 0 °C for 
40 minutes before filtering through a Kimwipe plug and concentrating down to give a 
colorless oil. Flash chromatography (5% to 70% EtOAc in hexanes) afforded epoxy 
mesylate 282, as a colorless oil (6.8 mg, 0.012 mmol, 84% yield). [α]D25 = +74° (c = 
0.735, CHCl3);  1H NMR (300 MHz,  CDCl3) δ 7.16 (td, J = 7.7, 1.3 Hz, 1H), 7.12 – 7.04 
(m, 3H), 6.78 (td, J = 7.6, 1.1 Hz, 1H), 6.75 (td, J = 7.4, 0.9 Hz, 1H), 6.59 (d, J = 7.5 Hz, 
1H), 6.41 (d, J = 7.8 Hz, 1H), 5.59 (s, 1H), 5.35 (s, 1H), 4.46 (td, J = 8.9, 1.8 Hz, 1H), 
4.16 (ddd, J = 10.2, 5.9, 1.5 Hz, 1H), 4.02 (d, J = 11.5 Hz, 1H), 3.84 (d, J = 11.5 Hz, 1H), 
3.04 (s, 3H), 2.95 (s, 3H), 2.78 (dd, J = 12.7, 6.2 Hz, 1H), 2.65 (dd, J = 7.2, 4.7 Hz, 1H), 
2.38 (d, J = 8.9 Hz, 2H), 2.28 (dd, J = 12.8, 11.0 Hz, 1H), 2.16 (dd, J = 14.4, 4.8 Hz, 1H), 
1.86 (dd, J = 14.4, 7.2 Hz, 1H), 1.47 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 166.9, 
165.8, 150.9, 147.0, 133.3, 129.7, 129.5, 128.5, 122.8, 122.4, 119.3, 118.2, 109.3, 106.3, 
84.2, 83.7, 73.3, 59.8, 59.2, 57.6, 57.5, 53.0, 51.3, 41.3, 41.0, 37.7, 36.9, 33.4, 23.3, 14.1; 
FTIR (NaCl, thin film): 3364, 3011, 2958, 2932, 1668, 1608, 1486, 1471, 1445, 1418, 
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1354, 1300, 1253, 1197, 1175, 1092, 1018, 978, 961, 896, 817, 750, 667, 644 cm-1; 
HRMS (MM) calc’d for C30H35N4O6S [M+H]+ 579.2272, found 579.2287. 
Preparation of aldehyde 283 
 
To a 50 mL flame-dried flask was added 3-allyl pyrroloindoline 265 (1.0 g, 2.7 
mmol, 1.0 equiv) and DCM (20 mL), followed by methacrolein (95%, 2.36 mL, 27.1 
mmol, 10 equiv). ortho-iPr-Hoveyda-Grubbs II catalyst (170 mg, 0.27 mmol, 10 mol %) 
was added as a DCM solution (4 mL) at last. The flask was equipped with a condenser 
and heated to 40 °C for 3 days. The reaction was then quenched with ethyl vinyl ether 
(1.5 mL) and filtered through a silica gel plug, eluting with EtOAc. The filtrate was 
concentrated down to give a brown oil. Flash chromatography (5% to 35% EtOAc in 
hexanes) afforded aldehyde 283 as a light brown thick oil (951 mg, 2.32 mmol, 86% 
yield). [α]D25 = +106° (c = 1.27, CHCl3); 1H NMR (500 MHz, CDCl3; compound exists as 
a 2.0:1 mixture of rotamers; the major rotamer is denoted by *, minor rotamer denoted by 
§) δ 9.26 (s, 1H§), 9.20 (s, 1H*), 7.14 (t, J = 7.6 Hz, 1H*, 1H§), 7.03 (d, J = 7.4 Hz, 1H*, 
1H§), 6.79 (s, 1H§), 6.73 (t, J = 7.4 Hz, 1H*), 6.60 – 6.51 (m, 1H§), 6.48 (d, J = 8.0 Hz, 
1H*), 6.33 – 6.17 (m, 1H§), 6.13 (t, J = 7.0 Hz, 1H*), 5.55 (s, 1H*), 5.38 (s, 1H§), 4.66 
(d, J = 7.5 Hz, 1H*), 4.38 (s, 1H§), 3.77 (s, 3H*), 3.71 (s, 3H§), 3.01 (s, 3H*), 2.83 (s, 
3H§), 2.74 (d, J = 7.7 Hz, 2H*, 2H§), 2.69 (d, J = 10.2 Hz, 1H*), 2.57 (s, 1H§), 2.44 (d, J 
= 13.0 Hz, 1H*), 2.18 (s, 1H§), 1.66 (s, 3H*, 3H§); 13C NMR (126 MHz, CDCl3) δ 
O
Me H
o-iPr-HG II
(10 mol %)
DCM, reflux
(86% yield)
(10 equiv)
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194.3*§, 172.4*, 170.2§, 158.6* (q, J = 37.3 Hz), 157.1§ (q, J = 39.4 Hz), 149.7*, 149.5§, 
147.4*, 147.2§, 141.5*§, 130.9*, 130.5§, 129.3§, 129.1*, 121.7*§, 119.9§, 118.9*, 115.7* 
(q, J = 288.7 Hz), 109.5§, 108.1*, 90.1*, 88.9§, 60.5§, 59.4*, 56.8§, 53.1*, 52.9*, 52.3§, 
42.4*, 39.1§, 36.2*, 35.5*, 34.6§, 34.2§, 9.2*§; FTIR (NaCl, thin film): 3421, 3052, 3026, 
2955, 2827, 2717, 1751, 1688, 1609, 1490, 1437, 1358, 1302, 1204, 1155, 1061, 1021, 
985, 932, 873, 850, 794, 754 cm-1; HRMS (MM) calc’d for C20H22F3N2O4 [M+H]+ 
411.1526, found 411.1531. 
Preparation of allylic alcohol 284 
 
To a 100 mL flask was added aldehyde 283 (636 mg, 1.55 mmol, 1.0 equiv) and 
methanol (31 mL). Then, cerium chloride heptahydrate (693 mg, 1.86 mmol, 1.2 equiv) 
was dissolved in methanol (2.5 mL), while NaBH4 (59 mg, 1.55 mmol, 1.0 equiv) was 
mixed with methanol (1.2 mL). The reaction was cooled to 0 °C. The pre-generated 
methanol solution of cerium chloride was added into the reaction flask, quickly followed 
by the slow addition of NaBH4 methanol solution. After reacting at 0 °C for 15 minutes, 
the reaction was quenched with saturated ammonium chloride solution (70 mL), followed 
by EtOAc (50 mL). The mixture was separated and aqueous layer was extracted with 
EtOAc (3 x 50 mL). Combined organic layers were washed with brine (120 mL), dried 
over Na2SO4, filtered, and concentrated down to give a grey oil. Flash chromatography 
(5% to 60% EtOAc in hexanes) afforded allylic alcohol 284 as a light brown thick oil 
N N O
HMe
Me H
O
N N O
HMe
Me OH
TFA
TFA
MeOH, 0 °C
NaBH4,
CeCl3•7H2O
OMe
OMe
(89% yield)
284
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(567 mg, 1.37 mmol, 89% yield). [α]D25 = +88° (c = 1.16, CHCl3); 1H NMR (500 MHz, 
CDCl3; compound exists as a 1.6:1 mixture of rotamers; the major rotamer is denoted by 
*, minor rotamer denoted by §) δ 7.11 (t, J = 7.6 Hz, 1H*, 1H§), 7.01 (d, J = 7.5 Hz, 1H*, 
1H§), 6.80 – 6.76 (m, 1H§), 6.71 (t, J = 7.4 Hz, 1H*), 6.53 (d, J = 7.9 Hz, 1H§), 6.46 (d, J 
= 7.9 Hz, 1H*), 5.52 (s, 1H*), 5.37 (s, 1H§), 5.25 (t, J = 7.2 Hz, 1H§), 5.13 (t, J = 7.4 Hz, 
1H*), 4.63 (d, J = 7.5 Hz, 1H*), 4.30 (t, J = 8.0 Hz, 1H§), 3.85 (s, 2H§), 3.83 (s, 2H*), 
3.77 (s, 3H*), 3.69 (s, 3H§), 3.02 (s, 3H*), 2.85 (s, 3H§), 2.61 (dd, J = 13.6, 9.3 Hz, 2H*, 
2H§), 2.53 – 2.44 (m, 1H*), 2.41 (d, J = 3.9 Hz, 2H§), 2.39 (d, J = 6.8 Hz, 2H*), 2.17 – 
2.09 (m, 1H§), 1.55 (s, 3H*, 3H§); 13C NMR (126 MHz, CDCl3) δ 172.5*, 170.6§, 158.7* 
(q, JC-F = 37.0 Hz), 157.4§ (q, JC-F = 38.1 Hz), 149.9§, 149.8*, 138.6*§, 132.3*, 132.1§, 
128.8§, 128.6*, 121.9§, 121.8*, 119.9§, 119.1*, 118.6*§, 115.8* (q, JC-F = 288.5 Hz), 
115.7§ (app d, JC-F = 286.6 Hz), 109.8§, 108.0*, 90.2*, 89.0§, 67.6*§, 60.5§, 59.4*, 57.6§, 
53.5*, 52.8*, 52.3§, 41.9*, 38.4§, 36.4*, 35.3§, 34.3*, 34.1§, 13.6*§; FTIR (NaCl, thin 
film): 3421, 3052, 2954, 2921, 2875, 1749, 1690, 1608, 1490, 1437, 1356, 1301, 1203, 
1155, 1062, 1021, 994, 931, 852, 794, 746, 727 cm-1; HRMS (MM) calc’d for 
C20H24F3N2O4 [M+H]+ 413.1683, found 413.1690. 
Preparation of epoxy alcohol 285 
 
To a flame-dried 50 mL flask was added Ti(OiPr)4 (31 µL, 0.105 mmol, 10 mol 
%), activated 4Å molecular sieves, and DCM (18 mL). The reaction flask was cooled to –
N N O
HMe
Me OH
TFA
OMe
284
(+)-diethyltartrate 
(12 mol %)
Ti(OiPr)4 (10 mol %)
tBuOOH (3 equiv)
4Å MS, DCM, –20 °C
N N O
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Me OH
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O
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(97% yield)
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20 °C (crushed ice mixed with NaCl at about 3 : 1 ratio). (+)-Diethyl-tartrate (21.5 µL, 
0.126 mmol, 12 mol %) was added. After stirring for 5 minutes, allylic alcohol 284 (432 
mg, 1.05 mmol, 1.0 equiv) was added as a DCM solution (2 mL). After 30 minutes, 
tBuOOH (5.0-6.0 M decane solution, 0.57 mL, 3.14 mmol, 3.0 equiv) was added. In 90 
minutes, the flask was warmed to 0 °C using an ice water bath. The reaction was 
quenched with freshly prepared FeSO4/citric acid solution (4 g FeSO4, 0.66 g citric acid 
monohydrate, 12 mL distilled water). The mixture was extracted with Et2O (4 x 20 mL). 
Combined organic layers were cooled to 0 °C and then treated with precooled 30% 
NaOH (w/v) in saturated NaCl solution (prepared using 30 g NaOH, 5 g NaCl, 90 ml 
distilled water). The mixture was stirred vigorously for 1 hour. Then two layers were 
separated and the aqueous layer was extracted with Et2O (2 x 80 mL). Combined organic 
layers were dried over MgSO4, filtered, and concentrated down to give a colorless oil. 
Flash chromatography (10% to 70% EtOAc in hexanes) afforded epoxy alcohol 285 (10 : 
1 mixture of epoxide diastereomers by 1H NMR),  as a white foam (434 mg, 1.01 mmol, 
97% yield). [α]D25 = +104° (c = 0.87, CHCl3); 1H NMR (500 MHz, CDCl3; compound 
exists as a 1.7 : 1 mixture of rotamers; the major rotamer is denoted by *, minor rotamer 
denoted by §) δ 7.17 (td, J = 7.7, 1.2 Hz, 1H*, 1H§), 7.03 (d, J = 7.3 Hz, 1H*, 1H§), 6.80 
(d, J = 8.4 Hz, 1H§), 6.77 (d, J = 7.2 Hz, 1H*), 6.56 (d, J = 8.4 Hz, 1H§), 6.52 (d, J = 8.7 
Hz, 1H*), 5.89 (s, 1H*), 5.82 (s, 1H§), 4.70 – 4.53 (m, 1H*), 4.33 (t, J = 8.1 Hz, 1H§), 
3.77 (s, 3H*), 3.73 (s, 3H§), 3.55 – 3.43 (m, 1H*, 1H§), 3.42 – 3.26 (m, 1H*, 1H§), 3.12 
(s, 3H*), 2.91 (s, 3H§), 2.85 – 2.78 (m, 1H§), 2.78 – 2.65 (m, 2H*), 2.61 – 2.50 (m, 1H§), 
2.41 (dd, J = 13.4, 4.7 Hz, 1H§), 2.22 (d, J = 14.7 Hz, 1H§), 2.12 (d, J = 12.5 Hz, 1H*), 
2.02 – 1.86 (m, 2H*), 1.78 (dd, J = 15.4, 8.6 Hz, 1H§), 1.23 (s, 3H§), 1.15 (s, 3H*); 13C 
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NMR (126 MHz, CDCl3) δ 172.4*, 170.6§, 158.6* (q, JC-F = 37.1 Hz), 157.6§ (q, JC-F = 
37.9 Hz), 150.2*§, 131.4*, 130.7§, 129.2*§, 122.0*§, 119.9§, 188.8*, 115.9* (q, JC-F = 
288.3 Hz), 109.5§, 108.3*, 90.1*, 88.8§, 65.0*§, 60.9§, 60.23*, 60.15*, 59.1*, 56.4*, 56.3§, 
52.9*§, 52.6*§, 42.9*, 40.4§, 36.8*, 35.7*, 34.9§, 34.8§, 14.3*§; FTIR (NaCl, thin film): 
3462, 3004, 2955, 1751, 1691, 1609, 1490, 1437, 1358, 1302, 1203, 1159, 1103, 1063, 
1034, 985, 928, 848, 754 cm-1; HRMS (MM) calc’d for C20H24F3N2O5 [M+H]+ 429.1632, 
found 429.1643. 
Preparation of epoxy mesylate 286 
 
 To a flame-dried 25 mL flask was added epoxy alcohol 285 (284 mg, 0.66 mmol, 
1.0 equiv) and DCM (6.6 mL). The reaction flask was cooled to 0 °C. Methanesulfonyl 
chloride (MsCl, 57 µL, 0.73 mmol, 1.1 equiv) was added, followed by Et3N (185 µL, 
1.33 mmol, 2.0 equiv). After stirring for 1 hour, the reaction was quenched with saturated 
NaHCO3 solution (15 mL). The aqueous layer was extracted with EtOAc (4 x 15 mL). 
Combined organic layers were washed with brine (30 mL), dried over Na2SO4, filtered, 
and concentrated down to give a colorless oil. Flash chromatography (5% to 60% EtOAc 
in hexanes) afforded epoxy mesylate 286 as a white foam (296 mg, 0.58 mmol, 89% 
yield; resulting epoxy mesylate diastereomers from previous step were readily separated 
at this stage). [α]D25 = +89° (c = 0.85, CHCl3); 1H (500 MHz, CDCl3; compound exists as 
a 1.7 : 1 mixture of rotamers; the major rotamer is denoted by *, minor rotamer denoted 
N N O
HMe
Me OH
TFA
O
N N O
HMe
Me OMs
TFA
O
MsCl, Et3N
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by §) δ 7.17 (t, J = 7.8 Hz, 1H*, 1H§), 7.04 (d, J = 7.3 Hz, 1H*, 1H§), 6.87 – 6.71 (m, 
1H*, 1H§), 6.65 – 6.47 (m, 1H*, 1H§), 5.87 (s, 1H*), 5.79 (s, 1H§), 4.60 (s, 1H*), 4.33 (s, 
1H§), 4.08 (d, J = 14.0 Hz, 1H§), 4.04 (d, J = 11.1 Hz, 1H*), 3.89 (s, 1H§), 3.85 (d, J = 
10.6 Hz, 1H*), 3.76 (s, 3H*), 3.73 (s, 3H§), 3.10 (s, 3H*), 2.94 (s, 3H*, 3H§), 2.88 (s, 
3H§), 2.72 (dt, J = 18.8, 9.4 Hz, 1H*, 1H§), 2.68 – 2.60 (m, 1H*), 2.55 (dd, J = 13.2, 8.1 
Hz, 1H§), 2.39 (dd, J = 13.4, 4.6 Hz, 1H*), 2.28 (d, J = 14.6 Hz, 1H§), 2.16 (d, J = 14.7 
Hz, 1H*), 2.13 – 2.06 (m, 1H§), 1.95 (t, J = 11.7 Hz, 1H§), 1.76 (dt, J = 15.0, 5.7 Hz, 
1H*), 1.34 (s, 3H§), 1.25 (s, 3H*); 13C NMR (126 MHz, CDCl3) δ 172.4*, 170.4§, 158.5* 
(q, JC-F = 37.3 Hz), 157.4§ (q, JC-F = 36.8 Hz), 150.1*§, 130.9*, 130.1§, 129.3*§, 121.9*§, 
119.7§, 118.8*, 115.8§ (q, JC-F = 288.7 Hz), 109.3§, 108.2*, 90.0*, 88.6§, 73.2§, 73.1*, 
60.2§, 59.0*, 57.4*§, 57.4*, 56.2§, 52.9*§, 52.4*§, 42.9*, 40.3§, 37.4*§, 36.7*, 35.3*, 34.5§, 
34.1§, 14.0*§; FTIR (NaCl, thin film): 3028, 2956, 1747, 1693, 1608, 1489, 1439, 1360, 
1303, 1203, 1175, 1160, 1106, 1063, 1022, 982, 962, 897, 846, 817, 755 cm-1; HRMS 
(MM) calc’d for C21H26F3N2O7S [M+H]+ 507.1407, found 507.1411. 
Preparation of epoxy iodide 287 
 
To a 10 mL flame-dried flask equipped with a condenser was added epoxy 
mesylate 286 (146 mg, 0.288 mmol, 1.0 equiv) and sodium iodide (432 mg, 2.88 mmol, 
10.0 equiv). Acetone (2.8 mL) was then added and the reaction was heated to 60 °C, 
resulting in a yellow clear solution gradually turning blurry. After 90 minutes, the 
reaction was cooled to room temperature and the mixture was quenched with saturated 
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NH4Cl solution (10 mL) and extracted with EtOAc (3 x 10 mL). Combined organic layers 
were washed with saturated NaHCO3 solution (50 mL) and brine (50 mL). It was dried 
over Na2SO4, filtered and concentrated down to give an oil. Flash chromatography (1% to 
25% EtOAc in hexanes) afforded epoxy iodide 287, as white foam (136 mg, 0.253 mmol, 
88% yield). [α]D25 = +110° (c = 0.545, CHCl3); 1H NMR (500 MHz, CDCl3; compound 
exists as a 1.7 : 1 mixture of rotamers the major rotamer is denoted by *, minor rotamer 
denoted by §) δ 7.20 (t, J = 7.7 Hz, 1H*, 1H§), 7.06 (d, J = 7.2 Hz, 1H*, 1H§), 6.88 – 6.76 
(m, 1H*, 1H§), 6.61 – 6.49 (m, 1H*, 1H§), 5.88 (s, 1H*), 5.78 (s, 1H§), 4.62 (s, 1H*), 4.35 
(s, 1H§), 3.79 (s, 3H*), 3.76 (s, 3H§), 3.14 (s, 3H*), 3.10 – 3.03 (m, 3H§), 2.93 (d, J = 10.7 
Hz, 2H*, 2H§), 2.79 – 2.62 (m, 1H*, 1H§), 2.62 – 2.53 (m, 1H§), 2.49 – 2.40 (m, 1H*), 
2.35 – 2.21 (m, 1H§), 2.15 (d, J = 15.1 Hz, 1H*), 2.02 – 1.87 (m, 1H§), 1.73 (dd, J = 14.6, 
8.1 Hz, 1H*), 1.45 (s, 3H§), 1.37 (s, 3H*); 13C NMR (126 MHz, CDCl3) δ  172.4*, 
170.5§, 158.6* (q, JC-F = 36.2, 35.4 Hz), 150.2*§, 131.3*, 130.5§, 129.3*§, 122.0*§, 119.9§, 
118.9*, 115.9* (q, JC-F = 288.9 Hz), 109.5§, 108.5*, 90.1*, 88.7§, 62.5*, 60.3§, 59.2*§, 
56.3§, 53.0*, 52.6§, 52.4*, 43.0*, 40.5§, 36.9*, 36.4*, 35.2§, 34.7§, 16.4*§, 13.1*§; FTIR 
(NaCl, thin film): 3444, 3054, 3022, 3005, 2956, 1747, 1699, 1608, 1489, 1435, 1386, 
1360, 1303, 1203, 1158, 1023, 986, 929, 853, 809, 755 cm-1; HRMS (MM) calc’d for 
C20H23F3N2O4I [M+H]+ 539.0649, found 539.0633. 
Preparation of amine 288 
 
264
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dppb (20 mol %)
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To a 25 mL flame-dried screw-cap Schlenk flask was added N-allyl 
pyrroloindoline 264 (500 mg, 1.36 mmol, 1.0 equiv) and dimethylbibarturic acid (636 
mg, 4.07 mmol, 3.0 equiv). The Schlenk flask was then evacuated and backfilled with 
argon three times. The solids were then dissolved in dry DCE (3.8 mL). In the meantime, 
in a 1-dram vial, Pd2(dba)3 (62 mg, 0.068 mmol, 5 mol %) and 1,4-
bis(diphenylphosphino)butane (dppb, 58 mg, 0.135 mmol, 10 mol %) were mixed in 
DCE (1.6 mL) and the mixture was allowed to stir at room temperature for 1 hour; then 
the resulting solution was added into Schlenk flask. The reaction was heated to 80 °C. 
After 4 days, the reaction was cooled to room temperature and quenched with saturated 
Na2CO3 aqueous solution (40 mL). The mixture was extracted with EtOAc (3 x 40 mL). 
Combined organic layers were washed with brine (100 mL). It was dried over Na2SO4, 
filtered and concentrated down to give a brown oil. Flash chromatography (1% to 20% 
EtOAc in hexanes) afforded amine 288, which was contaminated with phosphine oxide 
formed from the dppb ligand. The mixture was then subjected to preparative reverse 
phase HPLC (t = 0 – 14 min, 65% to 75% CH3CN in H2O; t = 14 – 15 min, 75% to 95% 
CH3CN in H2O; t = 15 – 17 min, 95% to 100% CH3CN in H2O; t = 17 – 17.5 min, 100% 
to 65% CH3CN in H2O; t = 17.5 – 25 min, 65% CH3CN in H2O; tR = 16.5 – 20.0 min), to 
give pure product 43 as a yellow oil (408 mg, 1.24 mmol, 92% yield). [α]D25 = –228° (c = 
0.93, CHCl3); 1H NMR (500 MHz, CDCl3; compound exists as a 3.4 : 1 mixture of 
rotamers; the major rotamer is denoted by *, minor rotamer denoted by §) δ 7.08 – 7.01 
(m, 1H*, 2H§), 7.00 (ddd, J = 7.4, 1.3, 0.6 Hz, 1H*), 6.75 (td, J = 7.4, 0.9 Hz, 1H§), 6.70 
(td, J = 7.5, 0.9 Hz, 1H*), 6.61 – 6.58 (m, 1H§), 6.58 (dt, J = 7.9, 0.7 Hz, 1H*), 5.45 (tt, J 
= 1.9, 1.1 Hz, 1H§), 5.34 (s, 1H*), 5.21 (br s, 1H§), 4.91 (dd, J = 8.7, 2.3 Hz, 1H§), 4.74 
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(ddd, J = 8.9, 1.9, 1.0 Hz, 1H*), 3.24 (s, 3H§), 3.12 (s, 3H*), 2.86 (d, J = 13.2 Hz, 1H*), 
2.70 (dd, J = 13.0, 2.3 Hz, 1H§), 2.50 (dd, J = 13.2, 8.5 Hz, 1H*), 2.33 (dd, J = 13.0, 8.7 
Hz, 1H§), 1.46 (s, 3H§), 1.42 (s, 3H*); 13C NMR (126 MHz, CDCl3) δ 170.0*, 169.5§, 
156.8* (q, JC-F = 37.3 Hz), 155.9§ (q, JC-F = 37.5 Hz), 148.8*, 147.6§, 131.3§, 131.0*, 
128.9*§, 122.8*, 122.7§, 119.4§, 119.0*, 116.2§ (q, JC-F = 287.4 Hz), 115.8* (q, JC-F = 
288.0 Hz), 108.9§, 108.8*, 84.6*, 83.2§, 60.7§, 60.1* (q, JC-F = 3.2 Hz), 54.4§, 52.4*, 52.2§, 
50.7*, 41.9*, 40.2§, 24.4§, 24.2*; FTIR (NaCl, thin film): 3401, 3055, 2957, 2929, 2871, 
2121, 1738, 1687, 1612, 1521, 1485, 1470, 1455, 1408, 1354, 1334, 1315, 1302, 1260, 
1204, 1148, 1104, 1065, 1034, 1018, 1000, 977, 939, 904, 865, 837, 748, 718 cm-1; 
HRMS (MM) calc’d for C15H16F3N2O3 [M+H]+ 329.1108, found 329.1113. 
Preparation of bis(pyrroloindoline) 289 
 
To a 0.5-dram vial was added amine 288 (76 mg, 0.23 mmol, 3.0 equiv), which 
was then co-evaporated with benzene (2 x 1 mL). Epoxy mesylate 286 (39 mg, 0.08 
mmol, 1.0 equiv) was added as a solid, followed by tetra-n-butylammonium iodide 
(TBAI, 5.7 mg, 0.015 mmol, 0.2 equiv), and acetonitrile (90 µL). DIPEA (20 µL, 0.12 
mmol, 1.5 equiv) was added at last. The vial was sealed using a Teflon cap and heated to 
90 °C for 5 days. It was then cooled to room temperature and quenched with saturated 
NaHCO3 aqueous solution (2 mL). The mixture was extracted with EtOAc (5 x 2 mL). 
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Combined organic layers were washed with brine (10 mL), dried over Na2SO4, filtered, 
and concentrated down to give a yellow liquid. Flash chromatography (1% to 28% 
EtOAc in hexanes) afforded bis(pyrroloindoline) 289 as a light yellow oil (41.9 mg, 
0.057 mmol, 74% yield). Starting material 288 can be recovered. [α]D25 = –21° (c = 0.61, 
CHCl3); 1H NMR (500 MHz, CD3CN; half of proton peaks in compound exist as a 1.6 : 1 
mixture of rotamers; the major rotamer is denoted by *, minor rotamer denoted by §) δ 
7.15 (td, J = 7.7, 1.2 Hz, 1H*, 1H§), 7.11 – 7.00 (m, 1H*, 1H§, 1H), 6.92 (dd, J = 7.3, 1.2 
Hz, 1H), 6.83 (t, J = 8.1 Hz, 1H§), 6.78 (t, J = 7.3 Hz, 1H*), 6.66 (t, J = 7.4 Hz, 1H), 6.56 
– 6.48 (m, 1H*, 1H§), 6.47 (d, J = 8.1 Hz, 1H), 5.90 (s, 1H*), 5.79 (s, 1H§), 5.37 (s, 1H), 
4.70 (d, J = 8.2 Hz, 1H), 4.64 – 4.55 (m, 1H*), 4.29 (t, J = 8.2 Hz, 1H§), 3.75 (s, 3H*), 
3.73 (s, 3H§), 3.59 – 3.35 (m, 2H*, 2H§), 3.13 (s, 3H), 3.05 (s, 3H*), 2.81 (s, 3H§), 2.78 
(d, J = 13.0 Hz, 1H), 2.73 (dd, J = 13.8, 9.4 Hz, 1H§), 2.67 – 2.59 (m, 1H*), 2.42 (dd, J = 
13.5, 4.4 Hz, 1H*), 2.31 (dd, J = 13.0, 8.4 Hz, 1H), 2.33 – 2.27 (m, 1H§), 2.21 (d, J = 
14.3 Hz, 1H*), 2.17 – 2.10 (m, 1H§), 1.87 (dt, J = 16.5, 6.3 Hz, 1H§), 1.76 – 1.60 (m, 
1H*), 1.30 (s, 3H§), 1.25 (s, 3H*, 3H); 13C NMR (126 MHz, CDCl3) δ 172.3*, 170.6§, 
169.6, 158.5* (q, JC-F = 37.4 Hz), 157.8§ (app d, JC-F = 41.7 Hz), 156.9 (q, JC-F = 36.8 Hz), 
150.8§, 150.5*, 149.5, 131.7*, 131.4, 131.0§, 129.3§, 129.1*, 128.9*§, 122.3*§, 122.0, 
120.1§, 118.8*, 118.3, 116.1 (q, JC-F = 288.5 Hz), 116.0* (q, JC-F = 288.6 Hz), 115.8§ (q, 
JC-F = 286.1 Hz), 110.0§, 108.5*, 107.3, 90.2*, 88.9, 88.8§, 60.2§, 60.0*, 60.0, 59.8§, 
59.5*, 59.1*§, 57.6*, 56.8§, 52.9*, 52.8*, 52.5§, 52.4, 52.1§, 50.6, 42.9*, 42.4, 40.1§, 
37.0*, 36.2*, 35.8§, 35.7§, 25.8, 15.5§, 15.4*; FTIR (NaCl, thin film): 2956, 2927, 1750, 
1694, 1608, 1491, 1436, 1357, 1341, 1302, 1255, 1206, 1155, 1105, 1065, 1034, 998, 
149
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944, 861, 845, 845, 747 cm-1; HRMS (MM) calc’d for C35H37F6N4O7 [M+H]+ 739.2561, 
found 739.2570. 
  When epoxy iodide 287 was used instead of epoxy mesylate, a 
42% yield of rearranged product 290 was isolated. [α]D25 = –122° (c = 
0.475, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.17 (td, J = 7.6, 1.3 
Hz, 1H), 7.03 (ddd, J = 7.3, 1.3, 0.5 Hz, 1H), 6.75 (td, J = 7.4, 1.0 Hz, 1H), 6.60 (d, J = 
8.3 Hz, 1H), 6.43 (d, J = 7.9 Hz, 1H), 5.23 (s, 1H), 4.94 (dt, J = 1.9, 1.0 Hz, 1H), 4.86 – 
4.74 (m, 1H), 4.33 (td, J = 8.1, 4.8 Hz, 1H), 3.99 (dd, J = 11.1, 4.4 Hz, 1H), 3.64 (s, 3H), 
2.89 (s, 3H), 2.65 (dd, J = 14.7, 4.9 Hz, 1H), 2.37 – 2.19 (m, 2H), 1.91 (dd, J = 11.8, 11.1 
Hz, 1H), 1.68 (d, J = 1.2 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 170.8, 156.3 (q, JC-F = 
37.6 Hz), 151.4, 143.3, 129.7, 129.4, 123.0, 118.0, 115.5 (q, JC-F = 287.9 Hz), 111.8, 
106.2, 101.7, 80.7, 55.3, 52.9, 50.9, 46.1, 39.2, 30.4, 17.9; FTIR (NaCl, thin film): 3307, 
2953, 2924, 2853, 1747, 1713, 1608, 1557, 1495, 1442, 1290, 1262, 1208, 1179, 1033, 
1021, 997, 959, 900, 743 cm-1; HRMS (MM) calc’d for C20H24F3N2O4 [M+H]+ 413.1683, 
found 413.1690. 
Preparation of bis(amino acid) 293 
 
A solution of lithium hydroxide (7.4 mg, 0.31 mmol, 5.0 equiv) in distilled water 
(200 µL) was added dropwise to a solution of bis(pyrroloindoline) 289 (45.7 mg, 0.062 
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mmol, 1.0 equiv) in THF (350 µL) and distilled water (150 µL). After stirring at room 
temperature for 6 hours, the reaction was quenched with 1M HCl until pH reached 7 (210 
µL). The resulting solution was concentrated down using rotavap to get rid of THF, and 
then put under high vacuum to give a yellow oil. It was dissolved in methanol and 
subjected to reverse phase preparative HPLC (10% to 60% CH3CN in H2O over 12 min, 
tR = 6.8 – 8.0 min), giving bis(amino acid) 293 as a white solid (22.3 mg, 0.043 mmol, 
70% yield). [α]D25 = +59° (c = 0.59, MeOH); 1H NMR (500 MHz, CD3OD) δ 7.20 – 7.15 
(m, 2H), 7.11 (dd, J = 7.6, 1.2 Hz, 1H), 7.09 (td, J = 8.0, 1.5 Hz, 1H), 6.79 (td, J = 7.4, 
0.8 Hz, 1H), 6.77 (td, J = 7.5, 0.8 Hz, 1H), 6.55 (dd, J = 8.2, 0.9 Hz, 1H), 6.21 (d, J = 7.9 
Hz, 1H), 5.21 (s, 1H), 4.88 (s, 1H), 4.10 (dd, J = 8.6, 3.2 Hz, 1H), 3.67 (d, J = 16.2 Hz, 
1H), 3.62 (d, J = 16.2 Hz, 1H), 3.51 (dd, J = 12.3, 5.9 Hz, 1H), 3.35 (dd, J = 8.2, 3.6 Hz, 
1H), 2.90 (s, 3H), 2.85 (dd, J = 13.5, 3.2 Hz, 1H), 2.64 (t, J = 12.7 Hz, 1H), 2.52 (dd, J = 
13.0, 5.9 Hz, 1H), 2.46 (dd, J = 13.5, 8.6 Hz, 1H), 2.19 (dd, J = 15.1, 3.7 Hz, 1H), 2.06 
(dd, J = 15.1, 8.2 Hz, 1H), 1.38 (s, 3H), 1.37 (s, 3H); 13C NMR (126 MHz, CD3OD) δ 
174.3, 173.5, 151.2, 149.7, 134.3, 133.7, 130.3, 130.0, 124.1, 124.0, 121.0, 120.0, 107.8, 
107.6, 93.4, 88.2, 62.2, 61.7, 61.3, 57.8, 57.7, 54.5, 54.4, 42.5, 42.4, 36.7, 33.1, 26.4, 
15.6; FTIR (NaCl, thin film): 3049, 2957, 2930, 2603, 1631, 1607, 1490, 1462,1451, 
1402, 1383, 1350, 1308, 1275, 1213, 1187, 1129, 1106, 1043, 1026, 921, 860, 741 cm-1; 
HRMS (MM) calc’d for C29H35N4O5 [M+H]+ 519.2602, found 519.2615. 
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Preparation of (+)-nocardioazine A (171) 
 
To a 0.5-dram vial was added bis(amino acid) 293 (2.9 mg, 0.006 mmol, 1.0 
equiv). It was co-evaporated with benzene (1 mL). DMF (280 µL) was added into the 
vial. At 0 °C, DIPEA (4.5 µL, 0.026 mmol, 4.6 equiv) was added, followed by 
bromotripyrrolidinophosphonium hexafluorophosphate (PyBroP, 10.4 mg, 0.022 mmol, 
4.0 equiv). After 5 minutes, the reaction was allowed to stir at room temperature. After 
24 hours, the reaction was quenched with saturated NaHCO3 solution (1 mL). The 
aqueous layer was extracted with EtOAc (5 x 1 mL). Combined organic layers were 
washed with brine (3 mL), dried over Na2SO4, filtered and concentrated down to give a 
light yellow oil. Flash chromatography (5% to 40% EtOAc in hexanes) afforded (+)-
nocardioazine A (171) as a white solid (1.7 mg, 0.0035 mmol, 63% yield). [α]D25 = +45° 
(c = 0.50, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.18 (td, J = 7.7, 1.3 Hz, 1H), 7.16 (td, 
J = 7.7, 1.3 Hz, 1H), 7.10 (td, J = 7.5, 1.0 Hz, 2H), 6.79 (td, J = 7.5, 0.9 Hz, 1H), 6.74 
(td, J = 7.4, 0.9 Hz, 1H), 6.49 (t, J = 7.3 Hz, 2H), 5.66 (s, 1H), 5.40 (s, 1H), 4.55 – 4.49 
(m, 2H), 3.73 (d, J = 15.3 Hz, 1H), 3.33 (dd, J = 11.0, 3.5 Hz, 1H), 3.28 (dd, J = 14.2, 1.8 
Hz, 1H), 2.93 (s, 3H), 2.80 (dd, J = 15.0, 3.4 Hz, 1H), 2.76 (d, J = 15.4 Hz, 1H), 2.62 (dd, 
J = 13.7, 9.2 Hz, 1H), 2.40 (dd, J = 14.3, 11.2 Hz, 1H), 2.31 (dd, J = 13.7, 8.8 Hz, 1H), 
1.53 (dd, J = 14.9, 10.7 Hz, 1H), 1.52 (s, 3H), 1.12 (s, 3H); 13C NMR (126 MHz, CDCl3) 
N NH OHMe
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N N
H OH
Me
O
PyBroP, DIPEA
DMF, 0.02 M, 23 °C
(+)-nocardioazine A (171)
OH
OH
H
N NO
O
N
N
H
Me
HMe H
Me
O(63% yield)
H
293
152
Chapter 3 – Enantioselective Total Synthesis of (+)-Nocardioazines A and B  
δ 169.8, 169.0, 149.0, 147.2, 133.7, 133.3, 128.9, 128.7, 121.7, 121.3, 118.7, 118.0, 
107.6, 105.5, 91.6, 88.2, 62.7, 61.8, 61.6, 59.3, 53.4, 51.2, 51.1, 40.2, 36.5, 35.0, 34.3, 
20.1, 14.2; FTIR (NaCl, thin film): 3051, 3011, 2956, 2923, 2871, 2821, 2793, 1681, 
1608, 1483, 1453, 1428, 1390, 1359, 1345, 1303, 1278, 1245, 1216, 1190, 1158, 1146, 
1119, 1095, 1068, 1053, 1038, 1024, 1001, 981, 966, 920, 909, 890, 874, 841, 829, 810, 
788, 750, 703 cm-1; HRMS (MM) calc’d for C29H31N4O3 [M+H]+ 483.2391, found 
483.2409. 
 
Table 3.5. Comparison of 1H NMR data for natural vs. synthetic (+)-nocardioazine 
A (171) 
 
Raju et al. Report,3 
Natural 
(+)-nocardioazine A 
1H NMR, 600 MHz, CDCl3 
This Work, 
Synthetic 
(+)-nocardioazine A 
1H NMR, 500 MHz, CDCl3 
δ 7.16 (ddd, J = 7.7, 7.5, 1.2 Hz, 1H) δ 7.18 (td, J = 7.7, 1.3 Hz, 1H) 
7.14 (ddd, J = 7.7, 7.7, 1.2 Hz, 1H) 7.16 (td, J = 7.7, 1.3 Hz, 1H) 
7.09 (dd, J = 7.6, 1.2 Hz, 1H) 7.10 (td, J = 7.5, 1.0 Hz, 2H) 
7.07 (dd, J = 7.4, 1.1 Hz, 1H) – 
6.76 (ddd, J = 7.6, 7.5, 0.8 Hz, 1H) 6.79 (td, J = 7.5, 0.9 Hz, 1H) 
6.73 (ddd, J = 7.7, 7.4, 0.7 Hz, 1H) 6.74 (td, J = 7.4, 0.9 Hz, 1H) 
6.48 (dd, J = 7.7, 0.8 Hz, 1H) 6.49 (t, J = 7.3 Hz, 2H) 
6.47 (dd, J = 7.7, 0.7 Hz, 1H) – 
5.64 (s, 1H) 5.66 (s, 1H) 
5.38 (s, 1H) 5.40 (s, 1H) 
4.50 (m, 1H) 4.55 – 4.49 (m, 2H) 
4.49 (m, 1H) – 
3.72 (d, J = 15.5 Hz, 1H) 3.73 (d, J = 15.3 Hz, 1H) 
3.30 (dd, J = 11.0, 3.7 Hz, 1H) 3.33 (dd, J = 11.0, 3.5 Hz, 1H) 
3.26 (dd, J = 14.4, 1.6 Hz, 1H) 3.28 (dd, J = 14.2, 1.8 Hz, 1H) 
2.91 (s, 3H) 2.93 (s, 3H) 
2.79 (dd, J = 11.0, 3.7 Hz, 1H) 2.80 (dd, J = 15.0, 3.4 Hz, 1H) 
2.74 (d, J = 15.5 Hz, 1H) 2.76 (d, J = 15.4 Hz, 1H) 
2.60 (dd, J = 13.7, 9.1 Hz, 1H) 2.62 (dd, J = 13.7, 9.2 Hz, 1H) 
2.38 (dd, J = 14.4, 11.0 Hz, 1H) 2.40 (dd, J = 14.3, 11.2 Hz, 1H) 
2.30 (dd, J = 13.7, 8.7 Hz, 1H) 2.31 (dd, J = 13.7, 8.8 Hz, 1H) 
1.51 (obscured, 1H) 1.53 (dd, J = 14.9, 10.7 Hz, 1H) 
1.50 (s, 3H) 1.52 (s, 3H) 
1.10 (s, 3H) 1.12 (s, 3H) 
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Table 3.6. Comparison of 13C NMR data for natural vs. synthetic (+)-nocardioazine 
A (171) 
 
Raju et al. Report,3 
Natural 
(+)-nocardioazine A 
13C NMR, 150 MHz, CDCl3 
This Work, 
Synthetic 
(+)-nocardioazine A 
13C NMR, 126 MHz, CDCl3 
Chemical Shift Difference, Δδ 
δ 169.6 δ 169.8 0.2 
168.8 169.0 0.2 
148.8 149.0 0.2 
146.9 147.2 0.3 
133.6 133.7 0.1 
133.0 133.3 0.3 
128.8 128.9 0.1 
128.4 128.7 0.3 
121.5 121.7 0.2 
121.1 121.3 0.2 
118.4 118.7 0.3 
117.8 118.0 0.2 
107.4 107.6 0.2 
105.4 105.5 0.1 
91.5 91.6 0.1 
88.0 88.2 0.2 
62.4 62.7 0.3 
61.7 61.8 0.1 
61.4 61.6 0.2 
59.2 59.3 0.1 
53.3 53.4 0.1 
51.0 51.2 0.2 
50.9 51.1 0.2 
40.1 40.2 0.1 
36.4 36.5 0.1 
34.9 35.0 0.1 
34.2 34.3 0.1 
19.9 20.1 0.2 
14.1 14.2 0.1 
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